Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 65
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Characterization of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Cuscó Pons, Pol, 1987-
  • García Fernàndez, Jordi
Background: One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results: Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions: We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders., Major financial support for this research was received from Spanish “Ministerio de Ciencia, Innovación y Universidades.” Grants BFU2015-68655-P and BFU2017-861152-P to J.G.F., RTI2018-100968-B-I00, 2017-SGR-738, H2020/2014-2020 under grant agreements n°667302, n°643051, and n°728018 to B.C., PGC2018-098229-B-I00 to J.L.F., BES-2016-077374 to E.A.-G., CVI-7290 Junta de Andalucía to A.R.M., SAF2016-80937-R (Ministerio de Economía y Competitividad/FEDER) to G.M., Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and BFU2017-83150-P to J.J.C, BFU2017-89780-R and P12-CTS-2257 to A.M.C. and SAF2016-76340-R and María de Maeztu Excellence Unit, Institute of Neurosciences to E.S.. E.N.P. held an FPI pre-doctoral fellowship (Spanish “Ministerio de Ciencia, Innovación y Universidades”).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

  • Postema, Merel C.
  • Vilarroya, Óscar
  • Francks, Clyde
Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/- mice

  • Cabana-Domínguez, Judit
  • Martín García, Elena, 1975-
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernández-Castillo, Noèlia
  • Comand, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction., This work was supported by the Spanish ‘Ministerio de Economía y Competitividad-MINECO’ (#SAF2017-84060-RAEI/FEDER-UE), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I068) to RM, ‘Fundació La Marató-TV3’ (#2016/20-30) and ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006) to EMG, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100), Spanish ‘Ministerio de Economía y Competitividad’ (#SAF2015-68341-R), ‘AGAURGeneralitat de Catalunya’ (#2017-SGR-738) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I050) to BC and (#PNSD-2020I042) to NFC. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE). JCD was supported by the H2020 CoCA and Eat2beNICE projects
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gene-wide association study reveals RNF122 ubiquitin ligase as a novel susceptibility gene for attention deficit hyperactivity disorder

  • Garcia Martínez, Iris
  • Sánchez-Mora, Cristina
  • Soler Artigas, María
  • Rovira, Paula
  • Pagerols, Mireia
  • Corrales, Montse
  • Calvo Sánchez, Eva
  • Richarte, Vanesa
  • Bustamante Pineda, Mariona
  • Sunyer Deu, Jordi
  • Cormand, Bru
  • Casas, Miguel
  • Ramos Quiroga, Josep Antoni
  • Ribasés, Marta
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood-onset neurodevelopmental condition characterized by pervasive impairment of attention, hyperactivity, and/or impulsivity that can persist into adulthood. The aetiology of ADHD is complex and multifactorial and, despite the wealth of evidence for its high heritability, genetic studies have provided modest evidence for the involvement of specific genes and have failed to identify consistent and replicable results. Due to the lack of robust findings, we performed gene-wide and pathway enrichment analyses using pre-existing GWAS data from 607 persistent ADHD subjects and 584 controls, produced by our group. Subsequently, expression profiles of genes surpassing a follow-up threshold of P-value < 1e-03 in the gene-wide analyses were tested in peripheral blood mononucleated cells (PBMCs) of 45 medication-naive adults with ADHD and 39 healthy unrelated controls. We found preliminary evidence for genetic association between RNF122 and ADHD and for its overexpression in adults with ADHD. RNF122 encodes for an E3 ubiquitin ligase involved in the proteasome-mediated processing, trafficking, and degradation of proteins that acts as an essential mediator of the substrate specificity of ubiquitin ligation. Thus, our findings support previous data that place the ubiquitin-proteasome system as a promising candidate for its involvement in the aetiology of ADHD., Over the course of this investigation, I.G. M. has been a recipient of a predoctoral fellowship from the Vall d’Hebron Research Institute (PRED-VHIR-2012), Barcelona, Spain, and currently she is a recipient of a contract from the 7th Framework Programme for Research, Technological Development and Demonstration, European Commission (AGGRESSOTYPE_FP7HEALTH2013/602805). C.S. M. is a recipient of a Sara Borrell contract from the Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spain (CD15/00199) and a mobility grant from the Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spain (MV16/00039). M.S. A. is a recipient of a contract from the Biomedical Research Networking Centre in Mental Health (CIBERSAM), Madrid, Spain. P.R. is a recipient of a predoctoral fellowship from the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Spain (2016FI_B 00899). M.P. is recipient of a predoctoral fellowship from the Vall d’Hebron Research Institute, Barcelona, Spain (PRED-VHIR-2013) and a research grant from the Deutscher Akademischer Austauschdienst (DAAD), Germany (Research Grants - Short-Term Grants, 2017). E.C. S. is a recipient of a predoctoral fellowship from the Collaborative Research Training Programme for Medical Doctors (PhD4MD), Centre for Genomic Regulation (CRG) and Vall d’Hebron Research Institute (VHIR), Barcelona, Spain (II14/00018). M.R. is a recipient of a Miguel de Servet contract from the Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spain (CP09/00119 and CPII15/00023). This investigation was supported by Instituto de Salud Carlos III (PI12/01139, PI14/01700, PI15/01789, PI16/01505), and cofinanced by the European Regional Development Fund (ERDF), Agència de Gestió d’Ajuts Universitaris i de Recerca-AGAUR, Generalitat de Catalunya (2014SGR1357, 2014SGR0932), Ministerio de Economía, Industria y Competitividad, Spain (SAF2012-33484, SAF2015-68341-R), the European College of Neuropsychopharmacology (ECNP network: ‘ADHD across the lifespan’), Departament de Salut, Generalitat de Catalunya, Spain, and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. This project has also received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the grant agreements No 667302 and 643051.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian disorders presenting with hyperactivity and/or inattention

  • Fernàndez-Castillo, Noèlia
  • Cabana-Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico, Bàrbara
  • Weber, Keike
  • Lesch, Klaus-Peter
  • Lao Grueso, Oscar, 1976-
  • Reif, Andreas
  • Cormand, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD. We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders., This work was supported mainly by funding from the European Union H2020 Program [H2020/2014–2020, grant agreements n° 667302, 643051 and 728018, corresponding to projects CoCA, coca-project.eu/; Eat2BeNice: newbrainnutrition.com/ (accessed on 16 December 2021); and MiND; www.mind-project.eu (accessed on 16 December 2021), respectively], and from the ‘ECNP network on ADHD across the lifespan’. NC-F received funding from ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health‘ [PNSD-2020I042] and was supported by a contract of the ‘Centro de Investigación Biomédica en Red de Enfermedades Raras' (CIBERER). BC received funding from the Spanish ‘Ministerio de Economía y Competitividad’ [SAF2015-68341-R, RTI2018-100968-B-100 and PID2021-1277760B-I100], ‘Plan Nacional sobre Drogas of the Spanish Ministry of Health’ [PNSD-2017I050] and AGAUR, ‘Generalitat de Catalunya’ [2017-SGR-738]. JC-D and BT were supported by the H2020 CoCA (n° 667302) and Eat2beNICE (n° 728018) projects. DBK was supported by the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 643051 (MiND) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-148273/2016-5). OL acknowledges the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020, Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness)—RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00 and Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller Cucala, Paula
  • Maceda Porto, Iago, 1986-
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand, Bru
  • Lao Grueso, Oscar, 1976-
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, the co-funding by the Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. O.L. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia) - GRC 2017 SGR 937, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302 and EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051. P.E.-C. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - FI_B1_00113. I.M. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - GRC 2014 SGR 615. A.D.B. and D.D. were supported by the Lundbeck Foundation (grant numbers R102-A9118 and R155-2014-1724). S.V.F. was supported by the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement - 602805, the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 667302 & 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. B.C. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - SAF2015-68341-R and RTI2018-100968-B-100, Generalitat de Catalunya | Agaur (Government of Catalonia) - GRC 2017 SGR 738, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302, EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051 and EC | EU Horizon 2020 Research and Innovation Proramme (Sustainable Food Security - Resilient and Resource - Efficient Value Chains) - 728018
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian Disorders presenting with hyperactivity and/or inattention

  • Fernàndez Castillo, Noèlia
  • Cabana Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico Avilés, Bàrbara
  • Weber, Heike
  • Lesch, Klaus-Peter
  • Lao, Oscar
  • Reif, Andreas
  • Cormand Rifà, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD.We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

  • Rovira, Paula
  • Demontis, Ditte
  • Sánchez Mora, Cristina
  • Zayats, Tetyana
  • Klein, Marieke
  • Roth Mota, Nina
  • Weber, Heike
  • Garcia-Martínez, Iris
  • Pagerols Teixidó, Mireia
  • Vilar, Laura
  • Arribas, Lorena
  • Richarte, Vanesa
  • Corrales, Montserrat
  • Fadeuilhe, Christian
  • Bosch, Rosa
  • Español, Gemma
  • Grevet, Eugenio Horacio
  • Halmøy, Anne
  • Hutz, Mara
  • Knappskog, Per M.
  • Lundervold, Aastri J.
  • Rovaris, Diego Luiz
  • Santos da Silva, Bruna
  • Sprooten, Emma
  • ADHD Working Group of the Psychiatric Genomics Consortium
  • Arias Vasquez, Alejandro
  • Sonuga-Barke, Edmund
  • Asherson, Philip
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan K.
  • Cormand Rifà, Bru
  • Faraone, Stephen V.
  • Haavik, Jan
  • Johansson, Stefan E.
  • Kuntsi, Jonna
  • Larsson, Henrik
  • Lesch, Klaus-Peter
  • Reif, Andreas
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Involvement of the 14-3-3 gene family in autism spectrum disorder and schizophrenia: Genetics, transcriptomics and functional analyses

  • Torrico Avilés, Bàrbara
  • Antón Galindo, Ester
  • Fernàndez Castillo, Noèlia
  • Rojo Francàs, Eva
  • Ghorbani, Sadaf
  • Pineda Cirera, Laura
  • Hervás, Amaia
  • Rueda, Isabel
  • Moreno Guillén, Estefanía
  • Fullerton, Janice M.
  • Casadó, Vicent
  • Buitelaar, Jan K.
  • Rommelse, Nanda
  • Franke, Barbara
  • Reif, Andreas
  • Chiocchetti, Andreas G.
  • Freitag, Christine
  • Kleppe, Rune
  • Haavik, Jan
  • Toma, Claudio
  • Cormand Rifà, Bru
The 14-3-3 protein family are molecular chaperones involved in several biological functions and neurological diseases. We previously pinpointed YWHAZ (encoding 14-3-3ζ) as a candidate gene for autism spectrum disorder (ASD) through a whole-exome sequencing study, which identified a frameshift variant within the gene (c.659-660insT, p.L220Ffs*18). Here, we explored the contribution of the seven human 14-3-3 family members in ASD and other psychiatric disorders by investigating the: (i) functional impact of the 14-3-3ζ mutation p.L220Ffs*18 by assessing solubility, target binding and dimerization; (ii) contribution of common risk variants in 14-3-3 genes to ASD and additional psychiatric disorders; (iii) burden of rare variants in ASD and schizophrenia; and iv) 14-3-3 gene expression using ASD and schizophrenia transcriptomic data. We found that the mutant 14-3-3ζ protein had decreased solubility and lost its ability to form heterodimers and bind to its target tyrosine hydroxylase. Gene-based analyses using publicly available datasets revealed that common variants in YWHAE contribute to schizophrenia (p = 6.6 × 10-7), whereas ultra-rare variants were found enriched in ASD across the 14-3-3 genes (p = 0.017) and in schizophrenia for YWHAZ (meta-p = 0.017). Furthermore, expression of 14-3-3 genes was altered in post-mortem brains of ASD and schizophrenia patients. Our study supports a role for the 14-3-3 family in ASD and schizophrenia.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine seeking behavior in Plcb1+/- mice

  • Cabana Domínguez, Judit
  • Martín-García, Elena
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder

  • Pineda Cirera, Laura
  • Shivalikanjli, Anu
  • Cabana Domínguez, Judit
  • Demontis, Ditte
  • Rajagopal, Veera M.
  • Børglum, Anders D.
  • Faraone, Stephen V.
  • Cormand Rifà, Bru
  • Fernàndez Castillo, Noèlia
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder caused by an interplay of genetic and environmental factors. Epigenetics is crucial to lasting changes in gene expression in the brain. Recent studies suggest a role for DNA methylation in ADHD. We explored the contribution to ADHD of allele-specific methylation (ASM), an epigenetic mechanism that involves SNPs correlating with differential levels of DNA methylation at CpG sites. We selected 3896 tagSNPs reported to influence methylation in human brain regions and performed a case-control association study using the summary statistics from the largest GWAS meta-analysis of ADHD, comprising 20,183 cases and 35,191 controls. We observed that genetic risk variants for ADHD are enriched in ASM SNPs and identified associations with eight tagSNPs that were significant at a 5% false discovery rate (FDR). These SNPs correlated with methylation of CpG sites lying in the promoter regions of six genes. Since methylation may affect gene expression, we inspected these ASM SNPs together with 52 ASM SNPs in high LD with them for eQTLs in brain tissues and observed that the expression of three of those genes was affected by them. ADHD risk alleles correlated with increased expression (and decreased methylation) of ARTN and PIDD1 and with a decreased expression (and increased methylation) of C2orf82. Furthermore, these three genes were predicted to have altered expression in ADHD, and genetic variants in C2orf82 correlated with brain volumes. In summary, we followed a systematic approach to identify risk variants for ADHD that correlated with differential cis-methylation, identifying three novel genes contributing to the disorder.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  • Franke, Barbara
  • Michelini, Giorgia
  • Asherson, Philip
  • Banaschewski, Tobias
  • Bilbow, Andrea
  • Buitelaar, Jan K.
  • Cormand Rifà, Bru
  • Faraone, Stephen V.
  • Ginsberg, Yiva
  • Haavik, Jan
  • Kuntsi, Jonna
  • Larsson, Henrik
  • Lesch, Klaus-Peter
  • Ramos-Quiroga, Josep Antoni
  • Réthelyi, János M.
  • Ribasés Haro, Marta
  • Reif, Andreas
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas, Jordi
  • Klein, Marieke
  • Zayats, Tetyana
  • Rivero, Olga
  • Ziegler, Georg C.
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy
  • Geissler, Julia
  • Weber, Heike
  • Reif, Andreas
  • Arias Vasquez, Alejandro
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan K.
  • Ramos Quiroga, Josep Antoni
  • Cormand Rifà, Bru
  • Ribasés Haro, Marta
  • Hveem, Kristian
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara
  • Lesch, Klaus-Peter
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (Ntotal = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence

  • Fernàndez Castillo, Noèlia
  • Cabana Domínguez, Judit
  • Soriano i Fradera, Jordi
  • Sánchez Mora, Cristina
  • Roncero, Carlos
  • Grau-López, Lara
  • Ros Cucurull, Elena
  • Daigre, Constanza
  • Van Donkelaar, Marjolein M. J.
  • Franke, B.
  • Casas, Miquel
  • Ribasés Haro, Marta
  • Cormand Rifà, Bru
Cocaine reward and reinforcing effects are mediated mainly by dopaminergic neurotransmission. In this study, we aimed at evaluating gene expression changes induced by acute cocaine exposure on SH-SY5Y-differentiated cells, which have been widely used as a dopaminergic neuronal model. Expression changes and a concomitant increase in neuronal activity were observed after a 5 μM cocaine exposure, whereas no changes in gene expression or in neuronal activity took place at 1 μM cocaine. Changes in gene expression were identified in a total of 756 genes, mainly related to regulation of transcription and gene expression, cell cycle, adhesion and cell projection, as well as mitogen-activeated protein kinase (MAPK), CREB, neurotrophin and neuregulin signaling pathways. Some genes displaying altered expression were subsequently targeted with predicted functional single-nucleotide polymorphisms (SNPs) in a case-control association study in a sample of 806 cocaine-dependent patients and 817 controls. This study highlighted associations between cocaine dependence and five SNPs predicted to alter microRNA binding at the 3′-untranslated region of the NFAT5 gene. The association of SNP rs1437134 with cocaine dependence survived the Bonferroni correction for multiple testing. A functional effect was confirmed for this variant by a luciferase reporter assay, with lower expression observed for the rs1437134G allele, which was more pronounced in the presence of hsa-miR-509. However, brain volumes in regions of relevance to addiction, as assessed with magnetic resonance imaging, did not correlate with NFAT5 variation. These results suggest that the NFAT5 gene, which is upregulated a few hours after cocaine exposure, may be involved in the genetic predisposition to cocaine dependence.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures

  • Roth Mota, Nina
  • Poelmans, Geert
  • Klein, Marieke
  • Torrico, Bàrbara
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
  • Reif, Andreas
  • Franke, Barbara
  • Arias Vasquez, Alejandro
Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N = 53,293, N = 681,275, and N = 98,697, respectively). We then conducted genome-wide ADHD-BMI and ADHD-obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD-BMI overlapping genes with brain volumes (primary GWAS data N = 10,720-10,928; replication data N = 9428). The dopaminergic gene set was associated with both ADHD (P = 5.81 × 10−3) and BMI (P = 1.63 × 10−5); the circadian rhythm was associated with BMI (P = 1.28 × 10−3). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD-BMI and ADHD-obesity results. The ADHD-BMI overlapping genes were associated with putamen volume (P = 7.7 × 10−3; replication data P = 3.9 × 10−2) a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD-obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Characterisation of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Vicente García, Cristina
  • Mirra, Serena
  • Burguera Hernández, Demian
  • Fernàndez Castillo, Noèlia
  • Ferrán, José Luis
  • López Mayorga, Macarena
  • Alaiz Noya, Marta
  • Suárez Pereira, Irene
  • Antón Galindo, Ester
  • Ulloa Darquea, Fausto Alexander
  • Herrera Úbeda, Carlos
  • Cuscó, Pol
  • Falcón Moya, Rafael
  • Rodríguez Moreno, Antonio
  • D&apos;Aniello, Salvatore
  • Cormand Rifà, Bru
  • Marfany i Nadal, Gemma
  • Soriano García, Eduardo
  • Carrión, Ángel M.
  • Carvajal, Jaime J.
  • Garcia Fernández, Jordi
Background One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder

  • García Martínez, Iris
  • Sánchez Mora, Cristina
  • Soler Artigas, María
  • Rovira, Paula
  • Pagerols Teixidó, Mireia
  • Corrales, Montserrat
  • Calvo Sánchez, Eva
  • Richarte, Vanesa
  • Bustamante Pineda, Mariona
  • Sunyer Deu, Jordi
  • Cormand Rifà, Bru
  • Casas, Miquel
  • Ramos Quiroga, Josep Antoni
  • Ribasés Haro, Marta
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood-onset neurodevelopmental condition characterized by pervasive impairment of attention, hyperactivity, and/or impulsivity that can persist into adulthood. The aetiology of ADHD is complex and multifactorial and, despite the wealth of evidence for its high heritability, genetic studies have provided modest evidence for the involvement of specific genes and have failed to identify consistent and replicable results. Due to the lack of robust findings, we performed gene-wide and pathway enrichment analyses using pre-existing GWAS data from 607 persistent ADHD subjects and 584 controls, produced by our group. Subsequently, expression profiles of genes surpassing a follow-up threshold of P-value < 1e-03 in the gene-wide analyses were tested in peripheral blood mononucleated cells (PBMCs) of 45 medication-naive adults with ADHD and 39 healthy unrelated controls. We found preliminary evidence for genetic association between RNF122 and ADHD and for its overexpression in adults with ADHD. RNF122 encodes for an E3 ubiquitin ligase involved in the proteasome-mediated processing, trafficking, and degradation of proteins that acts as an essential mediator of the substrate specificity of ubiquitin ligation. Thus, our findings support previous data that place the ubiquitin-proteasome system as a promising candidate for its involvement in the aetiology of ADHD.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller-Cucala, Paula
  • Maceda, Iago
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand Rifà, Bru
  • Lao, Oscar
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

  • Pagerols Teixidó, Mireia
  • Richarte, Vanesa
  • Sánchez Mora, Cristina
  • Rovira, Paula
  • Soler Artigas, María
  • Garcia-Martínez, Iris
  • Calvo-Sánchez, Eva
  • Corrales, Montserrat
  • Santos da Silva, Bruna
  • Roth-Mota, Nina
  • Victor, Marcelo Moraes
  • Rohde, Luis Augusto
  • Grevet, Eugenio Horacio
  • Bau, Claiton Henrique Dotto
  • Cormand Rifà, Bru
  • Casas, Miquel
  • Ramos Quiroga, Josep Antoni
  • Ribasés Haro, Marta
Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD paediatric patients. Although no variant reached genome-wide significance, the set of genes containing single-nucleotide polymorphisms (SNPs) nominally associated with MPH response (P < 0.05) was significantly enriched for candidates previously studied in ADHD or treatment outcome. We prioritised the nominally significant SNPs by functional annotation and expression quantitative trait loci (eQTL) analysis in human brain, and we identified 33 SNPs tagging cis-eQTL in 32 different loci (referred to as eSNPs and eGenes, respectively). Pathway enrichment analyses revealed an over-representation of genes involved in nervous system development and function among the eGenes. Categories related to neurological diseases, psychological disorders and behaviour were also significantly enriched. We subsequently meta-analysed the association with clinical outcome for the 33 eSNPs across the discovery sample and an independent cohort of 189 ADHD adult patients (target sample) and we detected 15 suggestive signals. Following this comprehensive strategy, our results provide a better understanding of the molecular mechanisms implicated in MPH treatment effects and suggest promising candidates that may encourage future studies.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller-Cucala, Paula
  • Maceda, Iago
  • Børglum, Andres D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand, Bru
  • Lao, Oscar
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, the co-funding by the Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. O.L. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia) - GRC 2017 SGR 937, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302 and EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051. P.E.-C. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - FI_B1_00113. I.M. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - GRC 2014 SGR 615. A.D.B. and D.D. were supported by the Lundbeck Foundation (grant numbers R102-A9118 and R155-2014-1724). High-performance computer capacity for handling and statistical analysis of iPSYCH and PGC data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine, Aarhus University and Central Region Denmark, and Centre for Integrative Sequencing, iSEQ, Aarhus University (grant to A.D.B.). S.V.F. was supported by the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement - 602805, the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 667302 & 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. B.C. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - SAF2015-68341-R and RTI2018-100968-B-100, Generalitat de Catalunya | Agaur (Government of Catalonia) - GRC 2017 SGR 738, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302, EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051 and EC | EU Horizon 2020 Research and Innovation Proramme (Sustainable Food Security - Resilient and Resource - Efficient Value Chains) - 728018., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas, Enrique
  • Vicente-García, Cristina
  • Mirra, Serena
  • Burguera, Demian
  • Fernández-Castillo, Noèlia
  • Ferrán, José Luis
  • López-Mayorga, Macarena
  • Alaiz-Noya, Marta
  • Suárez-Pereira, Irene
  • Antón-Galindo, Ester
  • Ulloa, Fausto
  • Herrera-Úbeda, Carlos
  • Cuscó, Pol
  • Falcón-Moya, Rafael
  • Rodríguez-Moreno, Antonio
  • D’Aniello, Salvatore
  • Cormand, Bru
  • Marfany, Gemma
  • Soriano, Eduardo
  • Carrión Rodríguez, Ángel Manuel
  • Carvajal, Jaime J.
  • Garcia-Fernàndez, Jordi
[Background]: One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood., [Results]: Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes., [Conclusions]: We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders., Major financial support for this research was received from Spanish “Ministerio de Ciencia, Innovación y Universidades.” Grants BFU2015-68655-P and BFU2017-861152-P to J.G.F., RTI2018-100968-B-I00, 2017-SGR-738, H2020/2014-2020 under grant agreements n°667302, n°643051, and n°728018 to B.C., PGC2018-098229-B-I00 to J.L.F., BES-2016-077374 to E.A.-G., CVI-7290 Junta de Andalucía to A.R.M., SAF2016-80937-R (Ministerio de Economía y Competitividad/FEDER) to G.M., Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and BFU2017-83150-P to J.J.C, BFU2017-89780-R and P12-CTS-2257 to A.M.C. and SAF2016-76340-R and María de Maeztu Excellence Unit, Institute of Neurosciences to E.S.. E.N.P. held an FPI pre-doctoral fellowship (Spanish “Ministerio de Ciencia, Innovación y Universidades”). S.M. was first supported by a contract with the “Centro de Investigación Biomédica en Enfermedades Neurodegenerativas,” and later by “Centro de Investigación Biomédica en Red de Enfermedades Raras” (CIBERER). N.F.C. is also under contract by CIBERER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

  • Sønderby, Ida E.
  • van der Meer, Dennis
  • Moreau, Clara
  • Kaufmann, Tobias
  • Bragi Walters, G.
  • Ellegaard, Maria
  • Abdellaoui, Abdel
  • Ames, David
  • Amunts, Katrin
  • Andersson, Micael
  • Armstrong, Nicola J.
  • Modenato, Claudia
  • Monereo Sánchez, Jennifer
  • Morris, Derek W.
  • Mühleisen, Thomas W.
  • Pausova, Zdenka
  • Olde Loohuis, Loes M.
  • Peralta, Juan M.
  • Pike, G. Bruce
  • Prieto, Carlos
  • Quinlan, Erin B.
  • Wright, Margaret J.
  • Reinbold, Céline S.
  • Stefansson, Hreinn
  • Reis Marques, Tiago
  • Bernard, Manon
  • Rucker, James J. H.
  • Sachdev, Perminder S.
  • Sando, Sigrid B.
  • Schofield, Peter R.
  • Schork, Andrew J.
  • Schumann, Gunter
  • Agartz, Ingrid
  • Shin, Jean
  • Shumskaya, Elena
  • Stefansson, Kari
  • Silva, Ana I.
  • Sisodiya, Sanjay M.
  • Blackburn, Nicholas B.
  • Steen, Vidar M.
  • Stein, Dan J.
  • Strike, Lachlan T.
  • Suzuki, Ikuo K.
  • Djurovic, Srdjan
  • Tamnes, Christian K.
  • Teumer, Alexander
  • Thalamuthu, Anbupalam
  • Jacquemont, Sébastien
  • Tordesillas-Gutiérrez, Diana
  • Uhlmann, Anne
  • Ulfarsson, Magnus O.
  • Blangero, John
  • van't Ent, Dennis
  • van den Bree, Marianne B. M.
  • Westlye, Lars T.
  • Vanderhaeghen, Pierre
  • Vassos, Evangelos
  • Wen, Wei
  • Wittfeld, Katharina
  • Thompson, Paul M.
  • Boomsma, Dorret I.
  • Andreassen, Ole A.
  • Brodaty, Henry
  • Brouwer, Rachel M.
  • Bülow, Robin
  • Bøen, Rune
  • Groenewold, Nynke A.
  • Cahn, Wiepke
  • Hashimoto, Ryota
  • Calhoun, Vincent
  • Caspers, Svenja
  • Ching, Christopher R. K.
  • Cichon, Sven
  • Ciufolini, Simone
  • Crespo-Facorro, Benedicto
  • Curran, Joanne E.
  • Dale, Anders M.
  • Gústafsson, Ómar
  • Dalvie, Shareefa
  • Dazzan, Paola
  • Hehir-Kwa, Jayne Y.
  • de Geus, de Geus,
  • Zubicaray, Greig I. de
  • de Zwarte, Sonja M. C.
  • Desrivieres, Sylvane
  • Doherty, Joanne L.
  • Donohoe, Gary
  • Draganski, Bogdan
  • Haavik, Jan
  • Ehrlich, Stefan
  • Eising, Else
  • Espeseth, Thomas
  • Hibar, Derrek P.
  • Fejgin, Kim
  • Fisher, Simon E.
  • Fladby, Tormod
  • Frei, Oleksandr
  • Frouin, Vincent
  • Fukunaga, Masaki
  • Haberg, Asta K.
  • Gareau, Thomas
  • Ge,Tian
  • Glahn, David C.
  • Grabe, Hans-Jörgen
  • Hillegers, Manon H. J.
  • Hall, Jeremy
  • Hoffmann, Per
  • Holleran, Laurena
  • Holmes, Avram J.
  • Homuth, Georg
  • Hottenga, Jouke-Jan
  • Murray, Robin M.
  • Hulshoff Pol, Hilleke E.
  • Ophoff, Roel A.
  • Ikeda, Masashi
  • Jahanshad, Neda
  • Jockwitz, Christiane
  • Johansson, Stefan
  • Jönsson, Erik G.
  • Jørgensen, Niklas R.
  • Kikuchi, Masataka
  • Knowles, Emma E. M.
  • Nielsen, Jacob
  • Kumar, Kuldeep
  • Le Hellard, Stephanie
  • Owen, Michael J.
  • Leu, Costin
  • Linden, David E. J.
  • Liu, Jingyu
  • Lundervold, Arvid
  • Lundervold, Astri Johansen
  • Maillard, Anne M.
  • Martin, Nicholas G.
  • Nordvik, Jan E.
  • Martin-Brevet, Sandra
  • Mather, Karen A.
  • Mathias, Samuel R.
  • Paus, Tomas
  • McMahon, Katie L.
  • McRae, Allan F.
  • Medland, Sarah E.
  • Meyer-Lindenberg, Andreas
  • Moberget,
  • Torgeir
  • Nyberg, Lars
ENIGMA-CNV working group., Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers—the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function., 1000BRAINS: The 1000BRAINS study was funded by the Institute of Neuroscience and Medicine, Research Center Juelich, Germany. We thank the Heinz Nixdorf Foundation (Germany) for the generous support of the Heinz Nixdorf Recall Study on which 1000BRAINS is based. We also thank the scientists and the study staff of the Heinz Nixdorf Recall Study and 1000BRAINS. Funding was also granted by the Initiative and Networking Fund of the Helmholtz Association (Caspers) and the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement 945539 (Human Brain Project SGA3; Amunts, Caspers, Cichon). Brainscale: The Brainscale study was supported by the Netherlands Organization for Scientific Research MagW 480-04-004 (Dorret I. Boomsma), 51.02.060 (Hilleke E. Hulshoff Pol), 668.772 (Dorret I. Boomsma and Hilleke E. Hulshoff Pol); NWO/SPI 56-464-14192 (Dorret I. Boomsma), the European Research Council (ERC-230374) (Dorret I. Boomsma), High Potential Grant Utrecht University (Hilleke E.Hulshoff Pol) and NWO Brain and Cognition 433-09-220 (Hilleke E.Hulshoff Pol). Betula: The Betula study was funded by the Knut and Alice Wallenberg (KAW) foundation (Nyberg). The Freesurfer segmentations on the Betula sample were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at HPC2N (in Umeå, Sweden), partially funded by the Swedish Research Council through grant agreement no. 2018-05973. Brain Imaging Genetics (BIG): This work makes use of the BIG database, first established in Nijmegen, The Netherlands, in 2007. This resource is now part of Cognomics (www.cognomics.nl), a joint initiative by researchers from the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Centre and the Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative has received support from the participating departments and centres and from external grants, that is, the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL), the Hersenstichting Nederland and the Netherlands Organization for Scientific Research (NWO). The research leading to these results also receives funding from the NWO Gravitation grant ‘Language in Interaction’, the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement nos. 602450 (IMAGEMEND), 278948 (TACTICS) and 602805 (Aggressotype), as well as from the European Community’s Horizon 2020 programme under grant agreement no. 643051 (MiND) and from ERC-2010-AdG 268800-NEUROSCHEMA. In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross-NIH partnership. deCODE genetics: deCODE genetics acknowledges support from the Innovative Medicines Initiative Joint Undertaking under grant agreement nos. 115008 (NEWMEDS) and 115300 (EUAIMS), of which resources are composed of EFPIA in-kind contribution and financial contribution from the European Union’s Seventh Framework Programme (EU-FP7/2007-2013), EU-FP7-funded grant agreement no. 602450 (IMAGEMEND) and EU-funded FP7-People-2011-IAPP grant agreement no. 286213 (PsychDPC). Dublin: This work was supported by Science Foundation Ireland (SFI grant 12/IP/1359 to Gary Donohoe and grant SFI08/IN.1/B1916-Corvin to Aidan C. Corvin). ECHO-DEFINE: The ECHO study acknowledges funding from a Medical Research Council (MRC) Centre Grant to Michael J. Owen (G0801418), the Wellcome Trust (Institutional Strategic Support Fund (ISSF) to van den Bree and Clinical Research Training Fellowship to Joanne L. Doherty), the Waterloo Foundation (WF 918-1234 to van den Bree), the Baily Thomas Charitable Fund (2315/1 to van den Bree), National Institute of Mental Health (NIMH 5UO1MH101724 to van den Bree and Michael J. Owen), the IMAGINE-2 study (funded by the MRC (MR/T033045/1) to van den Bree, Jeremy Hall and Michael J. Owen), the IMAGINE-ID study (funded by MRC (MR/N022572/1) to Jeremy Hall, van den Bree and Owen). The DEFINE study was supported by a Wellcome Trust Strategic Award (100202/Z/12/Z) to Michael J. Owen. ENIGMA: ENIGMA is supported in part by NIH grants U54 EB20403, R01MH116147 and R56AG058854. NIA T32AG058507; NIH/NIMH 5T32MH073526. EPIGEN-Dublin: The EPIGEN-Dublin cohort was supported by a Science Foundation Ireland Research Frontiers Programme award (08/RFP/GEN1538). EPIGEN-UK (Sisodiya): The work was partly undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health’s NIHR Biomedical Research Centres funding scheme. We are grateful to the Wolfson Trust and the Epilepsy Society for supporting the Epilepsy Society MRI scanner. GAP: This work was supported by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. GOBS: The GOBS study data collection was supported in part by the National Institutes of Health (NIH) grants: R01 MH078143, R01 MH078111 and R01 MH083824, with work conducted in part in facilities constructed under the support of NIH grant C06 RR020547. GSP: Data were in part provided by the Brain Genomics Superstruct Project (GSP) of Harvard University and Massachusetts General Hospital (MGH) (Principal Investigators: Randy Buckner, Jordan Smoller and Joshua Roffman), with support from the Center for Brain Science Neuroinformatics Research Group, Athinoula A. Martinos Center for Biomedical Imaging, Center for Genomic Medicine and Stanley Center for Psychiatric Research. Twenty individual investigators at Harvard and MGH generously contributed data to the overall project. We would like to thank Randy Buckner for insightful comments and feedback on this work. HUBIN: The HUBIN study was financed by the Swedish Research Council (K2010-62X-15078-07-2, K2012-61X-15078-09-3, 521-2014-3487 K2015-62X-15077-12-3, 2017-00949), the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet. HUNT: The HUNT study is a collaboration between HUNT Research Centre (Faculty of Medicine and Movement Sciences, NTNU—Norwegian University of Science and Technology), Nord-Trøndelag County Council, Central Norway Health Authority and the Norwegian Institute of Public Health. HUNT-MRI was funded by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology, and the Norwegian National Advisory Unit for functional MRI. IMAGEN: This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders) (695313), ERANID (Understanding the Interplay between Cultural, Biological and Subjective Factors in Drug Use Pathways) (PR-ST-0416-10004), BRIDGET (JPND: BRain Imaging, cognition Dementia and next generation GEnomics) (MR/N027558/1), Human Brain Project (HBP SGA 2, 785907),the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EUAIMS (115300-2), the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the Swedish Research Council FORMAS, the Medical Research Council, the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152, 01EV0711; eMED SysAlc01ZX1311A; Forschungsnetz AERIAL 01EE1406A, 01EE1406B), the Deutsche Forschungsgemeinschaft (DFG grants, SM 80/7-2, SFB 940/2), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1). Further support was provided by grants from: ANR (project AF12-NEUR0008-01—WM2NA, ANR-12-SAMA-0004), the Eranet Neuron (ANR-18-NEUR00002-01), the Fondation de France (00081242), the Fondation pour la Recherche Médicale (DPA20140629802), the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance-Publique-Hôpitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l’Avenir (grant AP-RM-17-013), the Fédération pour la Recherche sur le Cerveau; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), USA (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. Lifespan: The study is funded by the Research Council of Norway (230345, 288083 and 223273). NCNG: NCNG sample collection was supported by grants from the Bergen Research Foundation and the University of Bergen, the Dr Einar Martens Fund, the Research Council of Norway, to le Hellard, Steen and Espeseth. The Bergen group was supported by grants from the Western Norway Regional Health Authority (Grant 911593 to Arvid Lundervold, Grant 911397 and 911687 to Astri Johansen Lundervold). NTR: The NTR cohort was supported by the Netherlands Organization for Scientific Research (NWO) and The Netherlands Organisation for Health Research and Development (ZonMW) grants 904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004,463-06-001, 451-04-034, 400-05-717, Addiction-31160008, 016-115-035, 481-08-011, 056-32-010, Middelgroot-911-09-032, OCW_NWO Gravity programme—024.001.003, NWO-Groot 480-15-001/674, Center for Medical Systems Biology (CSMB, NWO Genomics), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL, 184.021.007 and 184.033.111); Spinozapremie (NWO-56-464-14192), KNAW Academy Professor Award (PAH/6635) and University Research Fellow grant (URF) to Dorret I. Boomsma; Amsterdam Public Health research institute (former EMGO+), Neuroscience Amsterdam research institute (former NCA); the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, grant 01413: ENGAGE and grant 602768: ACTION); the European Research Council (ERC Starting 284167, ERC Consolidator 771057, ERC Advanced 230374), Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the National Institutes of Health (NIH, R01D0042157-01A1, R01MH58799-03, MH081802, DA018673, R01 DK092127-04, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995); the Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health. Computing was supported by NWO through grant 2018/EW/00408559, BiG Grid, the Dutch e-Science Grid and SURFSARA. OATS: The OATS study has been funded by a National Health & Medical Research Council (NHMRC) and Australian Research Council (ARC) Strategic Award Grant of the Ageing Well, Ageing Productively Programme (ID No. 401162) and NHMRC Project Grants (ID Nos. 1045325 and 1085606). This research was facilitated through Twins Research Australia, a national resource in part supported by an NHMRC Centre for Research Excellence Grant (ID No.: 1079102). We thank the participants for their time and generosity in contributing to this research. We acknowledge the contribution of the OATS research team (https://cheba.unsw.edu.au/project/older-australian-twins-study) to this study. OATS genotyping was partly funded by a Commonwealth Scientific and Industrial Research Organization Flagship Collaboration Fund Grant. Osaka: Osaka study was supported by the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS: Grant Number JP18dm0207006), Brain/MINDS& beyond studies (Grant Number JP20dm0307002) and Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities (Grant Number JP20dk0307081) from the Japan Agency for Medical Research and Development (AMED), Grants-in-Aid for Scientific Research (KAKENHI; Grant Numbers JP25293250 and JP16H05375). Some computations were performed at the Research Center for Computational Science, Okazaki, Japan. PAFIP: The PAFIP study was supported by Instituto de Salud Carlos III, FIS 00/3095, 01/3129, PI020499, PI060507, PI10/00183, the SENY Fundació Research Grant CI2005-0308007 and the FundaciónMarqués de Valdecilla API07/011. Biological samples from our cohort were stored at the Valdecilla Biobank and genotyping services were conducted at the Spanish ‘Centro Nacional de Genotipado’ (CEGEN-ISCIII). MCIC/COBRE: The study is funded by the National Institutes of Health studies R01EB006841, P20GM103472 and P30GM122734 and Department of Energy DE-FG02-99ER62764. PING: Data collection and sharing for the Paediatric Imaging, Neurocognition and Genetics (PING) Study (National Institutes of Health Grant RC2DA029475) were funded by the National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health & Human Development. A full list of PING investigators is at http://pingstudy.ucsd.edu/investigators.html. QTIM: The QTIM study was supported by the National Institute of Child Health and Human Development (R01 HD050735) and the National Health and Medical Research Council (NHMRC 486682, 1009064), Australia. Genotyping was supported by NHMRC (389875). Medland is supported in part by an NHMRC fellowship (APP1103623). SHIP: SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grant nos. 01ZZ9603, 01ZZ0103 and 01ZZ0403), the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide single-nucleotide polymorphism typing in SHIP and MRI scans in SHIP and SHIP-TREND have been supported by a joint grant from Siemens Healthineers, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. StrokeMRI: StrokeMRI was supported by the Norwegian ExtraFoundation for Health and Rehabilitation(2015/FO5146), the Research Council of Norway (249795, 262372), the South-Eastern Norway Regional Health Authority (2014097, 2015044, 2015073) and the Department of Psychology, University of Oslo. Sydney MAS: The Sydney Memory and Aging Study (Sydney MAS) is funded by National and HealthMedical Research Council (NHMRC) Programme and Project Grants (ID350833, ID568969 and ID109308). We also thank the Sydney MAS participants and the Research Team. SYS: The SYS Study is supported by Canadian Institutes of Health Research. TOP: Centre of Excellence: RCN #23273 and RCN #226971. Part of this work was performed on the TSD (Tjeneste for Sensitive Data) facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (USIT) (tsd-drift@usit.uio.no). The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under grant agreement no. 609020—Scientia Fellows; the Research Council of Norway (RCN) #276082—A lifespan perspective on mental illness: toward precision medicine using multimodal brain imaging and genetics. Ida E. Sønderby and Rune Bøen are supported by South-Eastern Norway Regional Health Authority (#2020060). Ida E. Sønderby and Ole A. Andreassen have received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant agreement no. 847776 (CoMorMent project) and the KG Jebsen Foundation (SKGJ-MED-021). UCLA_UMCU: The UCLA_UMCU cohort comprises of six studies which were supported by National Alliance for Research in Schizophrenia and Affective Disorders (NARSAD) (20244 to Prof. Hillegers), The Netherlands Organisation for Health Research and Development (ZonMw) (908-02-123 to Prof. Hulshoff Pol), and Netherlands Organisation for Scientific Research (NWO 9120818 and NWO-VIDI 917-46-370 to Prof. Hulshoff Pol). The GROUP study was funded through the Geestkracht programme of the Dutch Health Research Council (ZonMw, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly and Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ inGeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord-Holland-Noord. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia Psycho-medical Center, The Hague. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGzE, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh, voor Geestelijke Gezondheid, Mondriaan, Virenzeriagg, Zuyderland GGZ, MET ggz, Universitair Centrum Sint-JozefKortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Utrecht: University Medical Center Utrecht and the mental health institutions: Altrecht, GGZ Centraal and Delta.). UK Biobank: This work made use of data sharing from UK Biobank (under project code 27412). Others: Work by Pierre Vanderhaeghen was funded by Grants of the European Research Council (ERC Adv Grant GENDEVOCORTEX), the EOS Programme, the Belgian FWO, the AXA Research Fund and the Belgian Queen Elizabeth Foundation. Ikuo K. Suzuki was supported by a postdoctoral fellowship of the FRS/FNRS., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years

  • Frangou, Sophia
  • Modabbernia, Amirhossein
  • Williams, Steven C. R.
  • Papachristou, Efstathios
  • Doucet, Gaelle E.
  • Agartz, Ingrid
  • Aghajani, Moji
  • Akudjedu, Theophilus N.
  • Albajes-Eizagirre, Antón
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Voineskos, Aristotle
  • Völzke, Henry
  • Walter, Henrik
  • Walton, Esther
  • Wang, Lei
  • Wang, Yang
  • Wassink, Thomas H.
  • Weber, Bernd
  • Bertolino, Alessandro
  • Wen, Wei
  • Kalnin, Andrew
  • West, John D.
  • Westlye, Lars T.
  • Whalley, Heather
  • Wierenga, Lara M.
  • Wittfeld, Katharina
  • Wolf, Daniel H.
  • Worker, Amanda
  • Wright, Margaret J.
  • Yang, Kun
  • Bonvino, Aurora
  • Kanai, Ryota
  • Yoncheva, Yulyia
  • Zanetti, Marcus V.
  • Ziegler, Georg C.
  • Karolinska Schizophrenia Project
  • Thompson, Paul M.
  • Dima, Danai
  • Boomsma, Dorret I.
  • Borgwardt, Stefan
  • Bourque, Josiane
  • Brandeis, Daniel
  • Klein, Marieke
  • Breier, Alan
  • Brodaty, Henry
  • Brouwer, Rachel M.
  • Buitelaar, Jan K.
  • Busatto, Geraldo F.
  • Buckner, Randy L.
  • Calhoun, Vincent
  • Canales-Rodríguez, Erick J.
  • Cannon, Dara M.
  • Caseras, Xavier
  • Klyushnik, Tatyana P.
  • Castellanos, Francisco X.
  • Cervenka, Simon
  • Chaim-Avancini, Tiffany M.
  • Ching, Christopher R. K.
  • Chubar, Victoria
  • Clark, Vincent P.
  • Conrod, Patricia
  • Conzelmann, Annette
  • Crespo-Facorro, Benedicto
  • Crivello, Fabrice
  • Koenders, Laura
  • Crone, Eveline A.
  • Dale, Anders M.
  • Dannlowski, Udo
  • Davey, Christopher
  • Geus, Eco J. C. de
  • Haan, Lieuwe de
  • Zubicaray, Greig I. de
  • den Braber, Anouk
  • Dickie, Erin W.
  • Di Giorgio, Annabella
  • Koops, Sanne
  • Doan, Nhat Trung
  • Dørum, Erlend S.
  • Ehrlich, Stefan
  • Erk, Susanne
  • Espeseth, Thomas
  • Fatouros-Bergman, Helena
  • Fisher, Simon E.
  • Fouche, Jean-Paul
  • Franke, Barbara
  • Frodl, Thomas
  • Krämer, Bernd
  • Fuentes-Claramonte, Paola
  • Glahn, David C.
  • Gotlib, Ian H.
  • Grabe, Hans-Jörgen
  • Grimm, Oliver
  • Groenewold, Nynke A.
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Gruner, Patricia
  • Gur, Rachel E.
  • Kuntsi, Jonna
  • Gur, Ruben C.
  • Hahn, Tim
  • Harrison, Ben J.
  • Hartman, Catharine A.
  • Hatton, Sean N.
  • Heinz, Andreas
  • Heslenfeld, Dirk J.
  • Hibar, Derrek P.
  • Hickie, Ian B.
  • Ho, Beng-Choon
  • Lagopoulos, Jim
  • Hoekstra, Pieter J.
  • Hohmann, Sarah
  • Holmes, Avram J.
  • Hoogman, Martine
  • Hosten, Norbert
  • Howells, Fleur M.
  • Hulshoff Pol, Hilleke E.
  • Huyser, Chaim
  • Jahanshad, Neda
  • James, Anthony
  • Lázaro, Luisa
  • Jernigan, Terry L.
  • Jiang, Jiyang
  • Jönsson, Erik G.
  • Joska, John A.
  • Kahn, René S.
  • Andersson, Micael
  • Lebedeva, Irina
  • Lee, Won Hee
  • Lesch, Klaus-Peter
  • Lochner, Christine
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Martin, Nicholas G.
  • Martínez-Zalacaín, Ignacio
  • Mataix-Cols, David
  • Mazoyer, Bernard
  • Andreasen, Nancy C.
  • McDonald, Colm
  • McDonald, Brenna C.
  • McIntosh, Andrew M.
  • McMahon, Katie L.
  • McPhilemy, Genevieve
  • Meinert, Susanne
  • Menchón, José M.
  • Medland, Sarah E.
  • Meyer-Lindenberg, Andreas
  • Naaijen, Jilly
  • Andreassen, Ole A.
  • Najt, Pablo
  • Nakao, Tomohiro
  • Nordvik, Jan E.
  • Nyberg, Lars
  • Oosterlaan, Jaap
  • Ortiz-Garcia de la Foz, Victor
  • Paloyelis, Yannis
  • Pauli, Paul
  • Pergola, Giulio
  • Pomarol-Clotet, Edith
  • Asherson, Philip
  • Portella, Maria J.
  • Potkin, Steven G.
  • Radua, Joaquim
  • Reif, Andreas
  • Rinker, Daniel A.
  • Roffman, Joshua L.
  • Rosa, Pedro G. P.
  • Sacchet, Matthew D.
  • Sachdev, Perminder S.
  • Salvador, Raymond
  • Banaschewski, Tobias
  • Sánchez-Juan, Pascual
  • Sarró, Salvador
  • Satterthwaite, Theodore D.
  • Saykin, Andrew J.
  • Serpa, Mauricio H.
  • Schmaal, Lianne
  • Schnell, Knut
  • Schumann, Gunter
  • Sim, Kang
  • Smoller, Jordan W.
  • Bargalló, Núria
  • Sommer, Iris
  • Soriano-Mas, Carles
  • Stein, Dan J.
  • Strike, Lachlan T.
  • Swagerman, Suzanne C.
  • Tamnes, Christian K.
  • Temmingh, Henk S.
  • Thomopoulos, Sophia I.
  • Tomyshev, Alexander S.
  • Baumeister, Sarah
  • Tordesillas-Gutiérrez, Diana
  • Trollor, Julian N.
  • Turner, Jessica A.
  • Uhlmann, Anne
  • van den Heuvel, Odile A.
  • van den Meer, Dennis
  • van der Wee, Nic J. A.
  • van Haren, Neeltje E. M.
  • van 't Ent, Dennis
  • van Erp, Theo G. M.
  • Baur-Streubel, Ramona
  • Veer, Ilya M.
  • Veltman, Dick J.
Special Issue: The ENIGMA Consortium: the first 10 years., Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3–90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes., European Community's Seventh Framework Programme, Grant/Award Numbers: 278948, 602450, 603016, 602805; US National Institute of Child Health and Human Development, Grant/Award Numbers: RO1HD050735, 1009064, 496682; QIMR Berghofer Medical Research Institute and the Centre for Advanced Imaging, University of Queensland; ICTSI NIH/NCRR, Grant/Award Number: RR025761; European Community's Horizon 2020 Programme, Grant/Award Numbers: 667302, 643051; Vici Innovation Program, Grant/Award Numbers: #91619115, 016-130-669; NWO Brain & Cognition Excellence Program, Grant/Award Number: 433-09-229; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Spinozapremie, Grant/Award Number: NWO-56-464-14192; Biobanking and Biomolecular Resources Research Infrastructure, Grant/Award Numbers: 184.033.111, 184.021.007; Netherlands Organization for Health Research and Development (ZonMW), Grant/Award Numbers: 480-15-001/674, 024.001.003, 911-09-032, 056-32-010, 481-08-011, 016-115-035, 31160008, 400-07-080, 400-05-717, 451-04-034, 463-06-001, 480-04-004, 904-61-193, 912-10-020, 985-10-002, 904-61-090; NIMH, Grant/Award Number: R01 MH090553; Geestkracht programme of the Dutch Health Research Council, Grant/Award Number: 10-000-1001; FP7 Ideas: European Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Grant/Award Numbers: NWO/SPI 56-464-14192, NWO-MagW 480-04-004, 433-09-220, NWO 51.02.062, NWO 51.02.061; National Center for Advancing Translational Sciences, National Institutes of Health, Grant/Award Number: UL1 TR000153; National Center for Research Resources; National Center for Research Resources at the National Institutes of Health, Grant/Award Numbers: NIH 1U24 RR025736-01, NIH 1U24 RR021992; NIH Institutes contributing to the Big Data to Knowledge; U.S. National Institutes of Health, Grant/Award Numbers: R01 CA101318, P30 AG10133, R01 AG19771; Medical Research Council, Grant/Award Numbers: U54EB020403, G0500092; National Institute of Mental Health, Grant/Award Numbers: R01MH117014, R01MH042191; Fundación Instituto de Investigación Marqués de Valdecilla, Grant/Award Numbers: API07/011, NCT02534363, NCT0235832; Instituto de Salud Carlos III, Grant/Award Numbers: PI14/00918, PI14/00639, PI060507, PI050427, PI020499; Swedish Research Council, Grant/Award Numbers: 523-2014-3467, 2017-00949, 521-2014-3487; South-Eastern Norway Health Authority; the Research Council of Norway, Grant/Award Number: 223273; South Eastern Norway Regional Health Authority, Grant/Award Numbers: 2017-112, 2019107; Icahn School of Medicine at Mount Sinai; Seventh Framework Programme (FP7/2007-2013), Grant/Award Number: 602450; National Institutes of Health, Grant/Award Numbers: R01 MH116147, R01 MH113619, R01 MH104284; South London and Maudsley NHS Foundation Trust; the National Institute for Health Research (NIHR)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic variants associated with longitudinal changes in brain structure across the lifespan

  • Brouwer, Rachel M.
  • Tordesillas-Gutiérrez, Diana
  • Crespo-Facorro, Benedicto
  • Hulshoff Pol, Hilleke E.
et al., Human brain structure changes throughout the lifespan. Altered brain growth or rates of decline are implicated in a vast range of psychiatric, developmental and neurodegenerative diseases. In this study, we identified common genetic variants that affect rates of brain growth or atrophy in what is, to our knowledge, the first genome-wide association meta-analysis of changes in brain morphology across the lifespan. Longitudinal magnetic resonance imaging data from 15,640 individuals were used to compute rates of change for 15 brain structures. The most robustly identified genes GPR139, DACH1 and APOE are associated with metabolic processes. We demonstrate global genetic overlap with depression, schizophrenia, cognitive functioning, insomnia, height, body mass index and smoking. Gene set findings implicate both early brain development and neurodegenerative processes in the rates of brain changes. Identifying variants involved in structural brain changes may help to determine biological pathways underlying optimal and dysfunctional brain development and aging., The ENIGMA-Plasticity Working Group is part of the ENIGMA World Aging Center, funded by NIA grants R56 AG058854 and R01 AG058854. The ENIGMA Consortium core funding was supported by NIH Consortium Grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence. 1000BRAINS: 1000BRAINS is a population-based cohort based on the Heinz-Nixdorf Recall Study and is supported, in part, by the German National Cohort. We thank the Heinz Nixdorf Foundation (Germany) for their generous support in terms of the Heinz Nixdorf Study. The authors are supported by the Initiative and Networking Fund of the Helmholtz Association (Svenja Caspers) and the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 785907 (Human Brain Project SGA2; Svenja Caspers, Sven Cichon and Katrin Amunts). This work was further supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under the auspices of the e:Med Program (grant 01ZX1314A; Sven Cichon) and by the Swiss National Science Foundation (SNSF, grant 156791; Sven Cichon). The authors acknowledge grants supporting their work from the European Union’s Horizon 2020 Research and Innovation Programme (H2020/2014–2020) under grant agreements 667302 (CoCA), 728018 (Eat2beNICE), 785907 (HBP SGA2) and 772376 (EScORIAL) and the Netherlands ALS Foundation.Additional support is received from the European Community’s Seventh Framework Programme (FP7/2007—2013) under grant agreements n° 602805 (Aggressotype), n° 603016 (MATRICS), n° 602450 (IMAGEMEND) and n° 278948 (TACTICS) and from the European Community’s Horizon 2020 Programme (H2020/2014—2020) under grant agreements n° 643051 (MiND) and n° 667302 (CoCA). FP7 Ideas: the European Research Council (ERC-230374 to D.B.). This work was supported by Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012 and PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM; Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds; European Union Seventh Framework Program under grant agreements FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 115916, Project PRISM and grant agreement 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz and Fundación Mutua Madrileña. The Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders) (695313). The FP7 project MATRICS (603016). The research leading to these results also received support from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement 278948 (TACTICS), 602805 (Aggressotype), 603016 (MATRICS) and 602450 (Imagemend) and the Innovation Medicine Initiative grants 115300 (EU-AIMS) and 777394 (AIMS-2-TRIALS).PAFIP: PAFIP was supported by the Instituto de Salud Carlos III (PI14/00639, PI14/00918 and PI17/01056) and Fundación Instituto de Investigación Marqués de Valdecilla (NCT0235832 and NCT025KG Jebsen Stiftelsen and H2020 CoMorMent (847776).34363). European Union Marie Curie Research Training Network (MRTN-CT-2006-035987)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Beyond the global brain differences: Intraindividual variability differences in 1q21.1 distal and 15q11.2 BP1-BP2 deletion carriers

  • Boen, Rune
  • Crespo-Facorro, Benedicto
  • Tordesillas-Gutiérrez, Diana
Rune Boen, et al., [Background]: Carriers of the 1q21.1 distal and 15q11.2 BP1-BP2 copy number variants exhibit regional and global brain differences compared with noncarriers. However, interpreting regional differences is challenging if a global difference drives the regional brain differences. Intraindividual variability measures can be used to test for regional differences beyond global differences in brain structure., [Methods]: Magnetic resonance imaging data were used to obtain regional brain values for 1q21.1 distal deletion (n = 30) and duplication (n = 27) and 15q11.2 BP1-BP2 deletion (n = 170) and duplication (n = 243) carriers and matched noncarriers (n = 2350). Regional intra-deviation scores, i.e., the standardized difference between an individual's regional difference and global difference, were used to test for regional differences that diverge from the global difference., [Results]: For the 1q21.1 distal deletion carriers, cortical surface area for regions in the medial visual cortex, posterior cingulate, and temporal pole differed less and regions in the prefrontal and superior temporal cortex differed more than the global difference in cortical surface area. For the 15q11.2 BP1-BP2 deletion carriers, cortical thickness in regions in the medial visual cortex, auditory cortex, and temporal pole differed less and the prefrontal and somatosensory cortex differed more than the global difference in cortical thickness., [Conclusions]: We find evidence for regional effects beyond differences in global brain measures in 1q21.1 distal and 15q11.2 BP1-BP2 copy number variants. The results provide new insight into brain profiling of the 1q21.1 distal and 15q11.2 BP1-BP2 copy number variants, with the potential to increase understanding of the mechanisms involved in altered neurodevelopment., 1000BRAINS. This work was supported by the Institute of Neuroscience and Medicine (INM-1), Research Centre Julich, European Union’s Horizon 2020 Research and Innovation Programme (Grant No. 945539 [HBP SGA3; SC]), and Joint Lab Supercomputing and Modeling for the Human Brain. We thank the Heinz Nixdorf Foundation for the generous support of the Heinz Nixdorf Study. We also thank the scientists and the study staff of the Heinz Nixdorf Recall Study and 1000BRAINS. We gratefully acknowledge the computing time granted through JARA-HPC on the supercomputer JURECA at Forschungszentrum Julich. TOP: This work was supported by Research Council of Norway (Grant Nos. 23273 (Centre of Excellence, Norwegian Centre for Mental Disorders, NORMENT), Grant Nos. 324252 and 226971). ENIGMA-CNV Working Group. This work was supported by the Research Council of Norway (Grant No. 223273 [to OAA]), South-Eastern Norway Regional Health Authority (Grant No. 2020060 [to IES, RB]), European Union’s Horizon 2020 Research and Innovation Programme (CoMorMent project; Grant No. 847776 [to IES]), Kristian Gerhard Jebsen Stiftelsen (Grant No. SKGJ-MED-021 [to IES]), and National Institute of Mental Health (NIMH) (Grant Nos. U01MH119736, R21MH116473, R01MH085953 [to CEB]), and 1R01MH129858-01A1 [to SJ]. This work was performed on Services for Sensitive Data, University of Oslo, with resources provided by UNINETT Sigma2, the national infrastructure for high performance computing and data storage in Norway. Australian Schizophrenia Research Bank: This work was supported by the Australian National Health and Medical Research Council (NHMRC) (Enabling Grant No. 386500, L3 Investigator Grant No. 1196508 [to CP]), and Program Grant No. APP1150083 [to CP]), Pratt Foundation, Ramsay Health Care, Viertel Charitable Foundation, and Schizophrenia Research Institute. Chief Investigators for the Australian Schizophrenia Research Bank were Vaughan Carr, US, RJS, Assen Jablensky, BJM, Patricia Michie, Stanley Catts, FAH, and CP. ECHO-DEFINE: This work was supported by the Wellcome Trust (Institutional Strategic Support Fund [to MBMvdB] and Clinical Research Training Fellowship Grant No. 102003/Z/13/Z [to JLD]), Waterloo Foundation (Grant No. WF 918-1234 [to MBMvdB]), Baily Thomas Charitable Fund (Grant No. 2315/1 [to MBMvdB]), NIMH (Grant Nos. 5UO1MH101724 and U01MH119738 [to MBMvdB]), IMAGINE-ID and IMAGINE-2 studies (funded by Medical Research Council Grant Nos. MR/N022572/1 and MR/T033045/1 [to MBMvdB]), and Medical Research Council (Centre Grant No. MR/P005748/1 [to MJO]). The DEFINE study was supported by a Wellcome Trust Strategic Award (Grant No. 100202/Z/12/Z [to MJO]). FOR2107 Marburg and Münster: This work is part of the German multicenter consortium “Neurobiology of Affective Disorders: A Translational Perspective on Brain Structure and Function,” supported by the German Research Foundation (Deutsche Forschungsgemeinschaft; Forschungsgruppe/Research Unit FOR2107). Principal investigators with respective areas of responsibility in the FOR2107 consortium: Work Package WP1, FOR2107/MACS cohort and brainimaging: TK (speaker FOR2107; DFG Grant Nos. KI 588/14-1, KI 588/14-2, KI 588/20-1, and KI 588/22-1), UD (co-speaker FOR2107; Grant Nos. DA 1151/5-1, DA 1151/5-2, and DA 1151/6-1), Axel Krug (Grant Nos. KR 3822/5-1 and KR 3822/7-2), IN (Grant Nos. NE 2254/1-2, NE 2254/3-1, and NE 2254/4-1), Carsten Konrad (Grant No. KO 4291/3-1). WP5, genetics: Marcella Rietschel (Grant Nos. RI 908/11-1 and RI 908/11-2), MMN (Grant Nos. NO 246/10-1 and NO 246/10-2), Stephanie Witt (Grant Nos. WI 3439/3-1 and WI 3439/3-2). WP6, multi-method data analytics: AJ (Grant Nos. JA 1890/7-1 and JA 1890/7-2), TH (Grant No. HA 7070/2-2). We are deeply indebted to all study participants and staff. A list of acknowledgments can be found at: www.for2107.de/acknowledgements. UCLA-Utrecht: This work was supported by the NIMH (Grant No. R01 MH090553 [to RAO]). The NIMH had no further role in study design, in the collection, analysis, and interpretation of the data, in the writing of the report, and in the decision to submit the paper for publication. QTIM: This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant No. R01 HD050735) and the NHMRC (Grant Nos. 486682 and 1009064). Genotyping was supported by the NHMRC (Grant No. 389875). BETULA: This work was supported by the Knut and Alice Wallenberg Foundation (scholar grant [to LN]). Freesurfer calculations were enabled by resources provided by the Swedish National Infrastructure for Computing at HPC2N, Umeå. SHIP (Study of Health in Pomerania): This work is part of the Community Medicine Research net of the University of Greifswald, Germany, which is supported by the Federal Ministry of Education and Research (Grant Nos. 01ZZ9603, 01ZZ0103, and 01ZZ0403), Ministry of Cultural Affairs, and Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data in SHIP have been supported by the Federal Ministry of Education and Research (Grant No. 03ZIK012) and a joint grant from Siemens Healthineers and the Federal State of Mecklenburg-West Pomerania. MRI scans in SHIP and SHIP-TREND have been supported by a joint grant from Siemens Healthineers and the Federal State of Mecklenburg-West Pomerania. PAFIP (Programa de Atención a las Fases Iniciales de Psicosis): This work was supported by the Instituto de Salud Carlos III (Grant Nos. 00/3095, 01/3129, PI020499, PI14/00639, PI17/01056, and PI14/00918), SENY Fundació (Research Grant No. CI2005 0308007), and Fundación Marqués de Valdecilla Instituto de Investigación Sanitaria Valdecilla (Grant Nos. A/02/07, NCT0235832, and NCT02534363). Osaka: This work was supported by the Japan Agency for Medical Research and Development (Grant Nos. JP21wm0425012, JP18dm0307002, JP22wm0525019, and JP22dk0207060) and Japan Society for the Promotion of Science KAKENHI (Grant Nos. JP20H03611, JP22H04926, and 20K15778). Some computations were performed at the Research Center for Computational Science, Okazaki, Japan (Project: NIPS, 18-IMS-C162, 19-IMS-C181, 20-IMS-C162, 21-IMS-C179, 22-IMS-C195). IMAGEN: This work was supported by the European Union–funded FP6 Integrated Project IMAGEN (Reinforcement-Related Behavior in Normal Brain Function and Psychopathology) (Grant No. LSHM-CT-2007-037286), Horizon 2020–funded ERC Advanced Grant STRATIFY (Brain Network Based Stratification of Reinforcement-Related Disorders) (Grant No. 695313), Medical Research Foundation and Medical Research Council (Grants Nos. MR/R00465X/1 and MRF-058-0004-RG-DESRI [Neurobiological Underpinning of Eating Disorders: Integrative Biopsychosocial Longitudinal Analyses in Adolescents] and MR/S020306/1 and MRF-058-0009-RG-DESR-C0759 [Establishing Causal Relationships Between Biopsychosocial Predictors and Correlates of Eating Disorders and Their Mediation by Neural Pathways]), National Institutes of Health (NIH) (Consortium Grant No. U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence, and Grant No. 1R56AG058854-01), National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, ERANID (Understanding the Interplay Between Cultural, Biological and Subjective Factors in Drug Use Pathways) (Grant No. PR-ST-0416-10004), BRIDGET (JPND: BRain Imaging, cognition Dementia and next generation GEnomics) (Grant No. MR/N027558/1), Human Brain Project (HBP SGA 2) (Grant No. 785907), FP7 project MATRICS (Grant No. 603016), Medical Research Council Grant Consortium on Vulnerability to Externalizing Disorders and Addictions (Grant No. MR/N000390/1), Bundesministerium für Bildung und Forschung (Grant Nos. 01GS08152, 01EV0711, Forschungsnetz AERIAL 01EE1406A, and 01EE1406B), Deutsche Forschungsgemeinschaft (Grant Nos. SM 80/7-2, SFB 940/2, and NE 1383/14-1), Agence Nationale de la Recherche (ANR) (Grant Nos. ANR-12-SAMA-0004 and AAPG2019 [GeBra]), Eranet Neuron (Grant Nos. AF12-NEUR0008-01 [WM2NA], ANR-18-NEUR00002-01 [ADORe], and ANR-12-SAMA-0004), Fondation de France (Grant No. 00081242), Fondation pour la Recherche Médicale (Grant No. DPA20140629802), Mission Interministérielle de Lutte contre les Drogues et les Conduites Addictives, Assistance Publique Hôpitaux de Paris and Institut National de la Santé et de la Recherche Médicale (Interface Grant), Paris Sud University IDEX 2012, Fondation de l’Avenir (Grant No. AP-RM-17-013), and Fédération pour la Recherche sur le Cerveau. MCIC (Mind Clinical Imaging Consortium): This work was supported by the NIH (NIH/National Center for Research Resources Grant No. P41RR14075 [to VC] and Grant No. R01EB005846 [to VC]), Department of Energy (Grant No. DE-FG02-99ER62764), Mind Research Network, Morphometry Biomedical Informatics Research Network (Grant Nos. 1U24 and RR021382A), Function Biomedical Informatics Research Network (Grant No. U24RR021992-01 [to VC], NIH/National Center for Research Resources Grant No. MO1 RR025758-01 [to VC], and NIMH Grant No. 1RC1MH089257 [to VC]), Deutsche Forschungsgemeinschaft (research fellowship [to SE]), and Brain and Behavior Research Foundation (NARSAD Young Investigator Award [to SE]). NTR (Netherlands Twin Register): This work was supported by the Netherlands Organization for Scientific Research (NWO) and Netherlands Organisation for Health Research and Development (Grant Nos. 904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004,463-06-001, 451-04-034, 400-05-717, Addiction-31160008, 016-115-035, 481-08-011, 056-32-010, Middelgroot-911-09-032, OCW_NWO Gravity programme—024.001.003, and NWO-Groot 480-15-001/674), Center for Medical Systems Biology (NWO Genomics), NBIC/BioAssist/RK (Grant No. 2008.024), Biobanking and Biomolecular Resources Research Infrastructure The Netherlands (Grant Nos. 184.021.007 and 184.033.111), Spinozapremie (Grant No. NWO-56-464-14192), Royal Netherlands Academy of Arts and Sciences Academy Professor Award (Grant No. PAH/6635) and University Research Fellow grant (to DIB), Amsterdam Public Health research institute (former EMGO+ Institute for Health and Care Research), Amsterdam Neuroscience (former Neuoscience Campus Amsterdam), European Science Foundation (Grant No. EU/QLRT-2001-01254), European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, Grant Nos. 01413: ENGAGE and 602768: ACTION), European Research Council (Grant Nos. ERC Starting 284167, ERC Consolidator 771057, and ERC Advanced 230374), Rutgers University Cell and DNA Repository (NIMH Grant No. U24 MH068457-06), NIH (Grant Nos. R01D0042157-01A1, R01MH58799-03, MH081802, DA018673, and R01 DK092127-04 and Grand Opportunity Grant Nos. 1RC2 MH089951 and 1RC2 MH089995), and Avera Institute for Human Genetics. The genotyping and analyses were partly funded by the Genetic Association Information Network of the Foundation for the National Institutes of Health. Computing was supported by NWO (Grant No. 2018/EW/00408559), BiG Grid, Dutch e-Science Grid, and SURFsara. OATS (Older Australian Twins Study): This work was supported by the NHMRC and Australian Research Council Strategic Award Grant of the Ageing Well, Ageing Productively Program (Grant No. 401162), NHMRC project (seed) grants (Grant Nos. 1024224 and 1025243), NHMRC project grants (Grant Nos. 1045325 and 1085606), and NHMRC program grants (Grant Nos. 568969 and 1093083). The OATS Study was facilitated through access to Twins Research Australia, a national resource supported by a Centre of Research Excellence Grant (Grant No. 1079102) from the NHMRC. We thank the participants for their time and generosity in contributing to this research. We acknowledge the contribution of the OATS research team (https://cheba.unsw.edu.au/project/older-australian-twins-study) to this study. PING (Pediatric Imaging, Neurocognition, and Genetics): This work was supported by the National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant Nos. RC2DA029475 and R01 HD061414). EPIGEN-London/University College London: The work was partly undertaken at University College London Hospitals NHS Foundation Trust/University College London, which received a proportion of funding from the UK Department of Health National Institute for Health Research Biomedical Research Centres funding scheme. We thank the Wolfson Trust and the Epilepsy Society for supporting the Epilepsy Society MRI scanner. OSR (Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffele)-Milan: This work was supported by the European Union H2020 (EU.3.1.1 Grant No. 754740 MOODSTRATIFICATION.EU), Italian Ministry of Health (Grant No. RF-2018-12367249) and Italian Ministry of University and Scientific Research (Grant No. A_201779W93T). Dublin: This work was supported by the European Research Council (Grant No. ERC-2015-STG-677467 [to GD]) and Science Foundation Ireland (Grant No. SFI-16/ERCS/3787 [to GD]). Brain Imaging Genetics (BIG): This work makes use of the BIG database, first established in Nijmegen, the Netherlands, in 2007. This resource is now part of Cognomics (www.cognomics.nl), a joint initiative by researchers from the Donders Centre for Cognitive Neuroimaging, Human Genetics and Cognitive Neuroscience departments of Radboud University Medical Centre, and Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative is supported by the participating departments and centers and Biobanking and Biomolecular Resources Research Infrastructure (Netherlands), Hersenstichting Nederland, and NWO. The research leading to these results also receives funding from the NWO (Gravitation Grant No. 024.001.006 Language in Interaction), European Community’s Seventh Framework Programme (FP7/2007-2013) (Grant Nos. 602450 IMAGEMEND, 278948 TACTICS, and 602805 Aggressotype), European Community’s Horizon 2020 programme (Grant Nos. 643051 MiND, and ERC-2010-AdG 268800-NEUROSCHEMA). In addition, the work was supported by the ENIGMA Consortium (Grant No. U54 EB020403) from the BD2K Initiative of a cross-NIH partnership. UK Biobank: This research has been conducted using the UK Biobank Resource under Application Number 27412. OAA has received speaker’s honorarium from Lundbeck, Janssen, and Sunovion and is a consultant to Coretechs.ai. TRM reports personal fees from Pfizer, Lundbeck, Astellas, Janssen, and Angelini outside the submitted work. He is an employee and shareholder of Pasithea Therapeutics. CRKC has received partial research support from Biogen for work unrelated to the topic of this article (principal investigator, PMT). PMT has received partial research support from Biogen for work unrelated to the topic of this article. MBMvdB and MJO report grants from Takeda Pharmaceuticals outside the submitted work. MJO reports a grant from Akrivia Health outside the submitted work. HJG has received travel grants and speaker’s honoraria from Fresenius Medical Care, Neuraxpharm, Servier, and Janssen as well as research funding from Fresenius Medical Care. GS has received honoraria for participating at advisory board meetings from Roche and Biogen regarding new Alzheimer’s disease drugs. KKS has received consultant and speaker’s honoraria from Roche and OrionPharma, reimbursement of travel and accommodation costs at a meeting from Kolpharma, and sponsorships for arranging conferences from Desitin and Eisai AB. IG has received speaker’s honorarium from Lundbeck. MMN has received fees for membership in an advisory board from HMG Systems Engineering GmbH, for membership in the Medical-Scientific Editorial Office of the Deutsches Ärzteblatt, and for serving as a consultant for Everis Belgium in a project of the European Commission (REFORM/SC2020/029). MMN also receives salary payments from Life & Brain GmbH and holds shares in Life & Brain GmbH. All these concerned activities outside the submitted work. CP received honoraria for talks from Lundbeck, Australia Pty Ltd. outside the submitted work. DJS has received consultancy honoraria from Discovery Vitality, Johnson & Johnson, Kanna, L’Oreal, Lundbeck, Orion, Sanofi, Servier, Takeda and Vistagen. JH has received speaker’s honorarium from Medice and Takeda outside the submitted work. KP reports work with Novo Nordisk and Roche clinical trials outside the submitted work. All other authors report no biomedical financial interests or potential conflicts of interest., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulėnaitė, Solveiga
  • García-Blanco, Alejandra
  • Mayneris-Perxachs, Jordi
  • Domingo-Rodríguez, Laura
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus
  • Espinosa-Carrasco, Jose
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández-Real, Jose Manuel
  • Maldonado, Rafael
  • Martín-García, Elena
Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish ’Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)’ (PID2020- 120029GB-I00/ MICIU/ AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ’Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ’Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ’La Marató de TV3’ #20221830, ’ICREA-Acadèmia’ (#2015) and the Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073- 2A to EM-G. Spanish-MINECO (#SAF2017-84060- R- AEI/ FEDER-UE) to LD-R, Spanish ’Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968- B- 100, #PID2021-127776OB- I00), ’AGAUR-Generalitat de Catalunya’ (#2017-SGR- 738, #2021-SGR- 01093) and Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT- K- 718- 03- 0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), ’La Marató de TV3’ #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB- I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the ’CERCA Programme/Generalitat de Catalunya’., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Paternally inherited cis-regulatory structural variants are associated with autism

  • Brandler, William M.
  • Antaki, Danny
  • Gujral, Madhusudan
  • Kleiber, Morgan L.
  • Whitney, Joe
  • Maile, Michelle S.
  • Hong, Oanh
  • Chapman, Timothy R.
  • Tan, Shirley
  • Tandon, Prateek
  • Pang, Timothy
  • Tang, Shih C.
  • Vaux, Keith K.
  • Yang, Yan
  • Harrington, Eoghan
  • Juul, Sissel
  • Turner, Daniel J.
  • Thiruvahindrapuram, Bhooma
  • Kaur, Gaganjot
  • Wang, Zhuozhi
  • Kingsmore, Stephen F.
  • Gleeson, Joseph G.
  • Bisson, Denis
  • Kakaradov, Boyko
  • Telenti, Amalio
  • Venter, J. Craig
  • Corominas, Roser
  • Toma, Claudio
  • Cormand, Bru
  • Rueda, Isabel
  • Guijarro, Silvina
  • Messer, Karen S.
  • Nievergelt, Caroline M.
  • Arranz, Maria J.
  • Courchesne, Eric
  • Pierce, Karen
  • Muotri, Alysson R.
  • Iakoucheva, Lilia M.
  • Hervas, Amaia
  • Scherer, Stephen W.
  • Corsello, Christina
  • Sebat, Jonathan
The genetic basis of autism spectrum disorder (ASD) is known to consist of contributions from de novo mutations in variant-intolerant genes. We hypothesize that rare inherited structural variants in cis-regulatory elements (CRE-SVs) of these genes also contribute to ASD. We investigated this by assessing the evidence for natural selection and transmission distortion of CRE-SVs in whole genomes of 9274 subjects from 2600 families affected by ASD. In a discovery cohort of 829 families, structural variants were depleted within promoters and untranslated regions, and paternally inherited CRE-SVs were preferentially transmitted to affected offspring and not to their unaffected siblings. The association of paternal CRE-SVs was replicated in an independent sample of 1771 families. Our results suggest that rare inherited noncoding variants predispose children to ASD, with differing contributions from each parent., This study was supported by grants to J.S. from NIH (MH076431 and MH113715) and the Simons Foundation Autism Research Initiative (SFARI) (275724) and by a gift to J.S. from the Beyster Family Foundation. Support to J.S. and K.K.V. was also provided from the ASD Enlight Foundation. Support for the generation of nanopore sequence data was provided by Oxford Nanopore Technologies. Funding for K.P. is from the National Institute of Mental Health (NIMH) (R01MH110558). Funding for E.C. is from NIMH (R01MH110558 and I-P50-MH081755) and a Simons Foundation Grant. L.M.I. was supported by NIH (R21 MH104766, R01 MH105524, and R01 MH109885) and in part by Simons Foundation grant 345469. S.W.S. holds the GlaxoSmithKline–Canadian Institutes of Health Research Chair in Genome Sciences at the University of Toronto and the Hospital for Sick Children. Funding for B.C. is from Ministerio de Economía, Industria y Competitividad (SAF2015-68341-R), Agència de Gestió d’Ajuts Universitaris i de Recerca (2014-SGR-0932), La Marató de TV3 (092020), and the European Commission H2020 Programme MiND (643051). A.H. and M.J.A. received grant support from the Institute Carlos III (FIS PI11/00620) and Mutua Terrassa (FMT grant BE062). Support for the generation of nanopore sequence data was provided by Oxford Nanopore Technologies. Funding for C.T. was provided by La Marató de TV3 (092010). Postdoctoral fellowships were provided to W.B. from the Autism Science Foundation and to M.L.K. from the Canadian Institutes of Health Research. A T32 training grant was provided to D.A. from NIH (GM008666). Funding for collection of fibroblast cell lines was provided by a grant (IT1-06611) to J.G.G. from the California Institute for Regenerative Medicine. A.R.M. is supported by a grant from the National Alliance for Research on Schizophrenia and Depression and NIH grants R01MH108528 and R01MH109885. S.F.K. is supported by NIH grant HD0077693. A.H. is supported by a grant from the Spanish Ministry of Health (FIS PI/15/01295 IP). We thank Genome Canada and the Centre for Applied Genomics (TCAG) for contributing the replication data set from the Autism Speaks MSSNG cohort (www.mss.ng). Author contributions: Conceptualization, J.S., W.M.B.; Methodology, W.M.B., D.A., M.G., J.S.; Software, D.A., W.M.B., M.G.; Validation, M.S.M., T.R.C., S.T., M.L.K., Y.Y., E.H.; Formal Analysis, W.M.B., D.A., M.G., M.L.K., J.W., P.T., K.S.M.; Writing–Original Draft, W.M.B., J.S.; Writing–Review and Editing, L.M.I., D.J.T., A.R.M., C.M.N., K.S.M.; Resources, K.K.V., T.P., S.C.T., D.B., B.K., A.T., J.C.V., C.C., A.R.M., R.C., B.C., L.M.I., S.G., A.H., M.J.A., I.R., S.J., D.J.T., S.F.K., J.G.G., E.C., K.P., S.W.S., B.T., G.K.; Visualization, W.M.B., D.A.; Supervision, J.S.; Project Administration, O.H.; Funding Acquisition, J.S., W.M.B., D.A., M.K. Competing interests: J.S. declares that a patent has been issued to the Cold Spring Harbor Laboratory by the U.S. Patent and Trademark Office on genetic methods for the diagnosis of autism (patent number 8554488). W.M.B., B.K., A.T., and J.C.V. are employed by Human Longevity, Inc. Y.Y., E.H., S.J., and D.J.T. work for Oxford Nanopore Technologies, Inc. A.R.M. is a cofounder and has equity interest in TISMOO, a company dedicated to genetic analysis focusing on therapeutic applications customized for autism spectrum disorder and other neurological disorders with genetic origins. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. Data and materials availability: The data reported in this paper are archived at the National Database for Autism Research (DOI:10.15154/1340302), including the structural variant callset and raw sequence (FASTQ), alignment (BAM), and variant call (VCF) files from the REACH cohort. We appreciate obtaining access to Simons Simplex Collection genomic and phenotypic data on SFARI Base. Approved researchers can obtain the SSC population data set described in this study (https://sfari.org/resources/autism-cohorts/simons-simplex-collection) by applying at https://base.sfari.org., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes

  • Torrico, Bàrbara
  • Shaw, Alex D.
  • Mosca, Roberto
  • Vivó-Luque, Norma
  • Hervás, Amaia
  • Fernàndez-Castillo, Noèlia
  • Aloy, Patrick
  • Bayés, Mònica
  • Fullerton, Janice M.
  • Cormand, Bru
  • Toma, Claudio
Previous research has implicated de novo and inherited truncating mutations in autism-spectrum disorder. We aim to investigate whether the load of inherited truncating mutations contributes similarly to high-functioning autism, and to characterize genes that harbour de novo variants in high-functioning autism., C. Toma was supported by the European Union (Marie Curie, PIEF-GA-2009-254930) and B. Torrico by AGAUR (Generalitat de Catalunya). Financial support was received from Fundació La Marató de TV3 (092010), Fundación Alicia Koplowitz, AGAUR (2017SGR738), the Spanish Ministerio de Economía y Competitividad (SAF2015-68341-R) and the Australian National Medical and Health Research Council (NHMRC) Project Grant 1063960 and 1066177, and Program Grant 1037196. The research leading to these results also received funding from the European Union H2020 Program (H2020/2014-2020) under grant agreements 667302 (CoCA) and 643051 (MiND). P. Aloy acknowledges the support of the Spanish Ministerio de Economía y Competitividad (BIO2013-48222-R; BIO2016-77038-R) and the European Research Council (SysPharmAD: 614944). J.M. Fullerton was supported by the Janette Mary O’Neil Research Fellowship. N. Fernàndez-Castillo was supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). Exome sequencing services were provided by the National Centre for Genomic Analysis (CNAG). The authors also thank the CIBERER Biobank (www.ciberer-biobank.es/), Rafael Valdés-Mas and Xose S. Puente from the University of Oviedo (Spain) for support in bioinformatics analyses, and Barbara Toson (NeuRA) for support in statistical analyses., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries

  • García-Marín, Luis M.
  • Campos, Adrian I.
  • Diaz-Torres, Santiago
  • Crespo-Facorro, Benedicto
  • Romero García, Rafael
  • Tordesillas-Gutiérrez, Diana
  • Vázquez-Bourgon, Javier
García-Marín, Luis M.; Campos, Adrian I.; Diaz-Torres, Santiago; et al., Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. Here we performed genome-wide association studies meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus, globus pallidus, thalamus, nucleus accumbens, amygdala and the ventral diencephalon) in 74,898 participants of European ancestry. We identified 254 independent loci associated with these brain volumes, explaining up to 35% of phenotypic variance. We observed gene expression in specific neural cell types across differentiation time points, including genes involved in intracellular signaling and brain aging-related processes. Polygenic scores for brain volumes showed predictive ability when applied to individuals of diverse ancestries. We observed causal genetic effects of brain volumes with Parkinson's disease and attention-deficit/hyperactivity disorder. Findings implicate specific gene expression patterns in brain development and genetic variants in comorbid neuropsychiatric disorders, which could point to a brain substrate and region of action for risk genes implicated in brain diseases., This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Specific Grant Agreement 945539 (Human Brain Project SGA3). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643417, No 640643, and No 667375 and 754517. IMAGEN was funded by the European Union-funded FP6 Integrated Project IMAGEN (LSHM-CT- 2007-037286). The MCIC study was supported by the National Institutes of Health (NIH/NCRR P41RR14075 and R01EB005846), the Department of Energy (DE-FG02-99ER62764). NeuroIMAGE also received funding from the European Community’s Seventh Framework Programme (FP7/2007– 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community’s Horizon 2020 Programme (H2020/2014– 2020) under grantagreements n°643051(MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). Additional support is received from the European Community's Seventh Framework Programme (FP7/2007– 2013) under grant agreements nº 602805 (Aggressotype), nº 603016 (MATRICS), nº 602450 (IMAGEMEND), and nº 278948 (TACTICS), and from the European Community's Horizon 2020 Programme (H2020/2014– 2020) under grant agreements nº 643051 (MiND) and nº 667302(CoCA). Erasmus Rucphen family study (ERF): The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no.QLG2-CT-2002-01254). the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, grant 01413: ENGAGE and grant 602768: ACTION); the European Research Council (ERC Starting 284167, ERC Consolidator 771057, ERC Advanced 230374). The Horizon 2020 supported programme CANDY Grant No. 847818). European Community’s Horizon 2020 Programme (H2020/2014– 2020) under grant agreement n° 847879 (PRIME). European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998). This work was supported by Fundación Marqués de Valdecilla, Instituto de investigación sanitaria Valdecilla., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller-Cucala, Paula
  • Maceda, Iago
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand Rifà, Bru
  • Lao, Oscar
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gene-wide association study reveals RNF122 ubiquitin ligase as a novel susceptibility gene for attention deficit hyperactivity disorder

  • Garcia Martínez, Iris
  • Sánchez-Mora, Cristina
  • Soler Artigas, María
  • Rovira, Paula
  • Pagerols, Mireia
  • Corrales, Montse
  • Calvo Sánchez, Eva
  • Richarte, Vanesa
  • Bustamante Pineda, Mariona
  • Sunyer Deu, Jordi
  • Cormand, Bru
  • Casas, Miguel
  • Ramos Quiroga, Josep Antoni
  • Ribasés, Marta
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood-onset neurodevelopmental condition characterized by pervasive impairment of attention, hyperactivity, and/or impulsivity that can persist into adulthood. The aetiology of ADHD is complex and multifactorial and, despite the wealth of evidence for its high heritability, genetic studies have provided modest evidence for the involvement of specific genes and have failed to identify consistent and replicable results. Due to the lack of robust findings, we performed gene-wide and pathway enrichment analyses using pre-existing GWAS data from 607 persistent ADHD subjects and 584 controls, produced by our group. Subsequently, expression profiles of genes surpassing a follow-up threshold of P-value < 1e-03 in the gene-wide analyses were tested in peripheral blood mononucleated cells (PBMCs) of 45 medication-naive adults with ADHD and 39 healthy unrelated controls. We found preliminary evidence for genetic association between RNF122 and ADHD and for its overexpression in adults with ADHD. RNF122 encodes for an E3 ubiquitin ligase involved in the proteasome-mediated processing, trafficking, and degradation of proteins that acts as an essential mediator of the substrate specificity of ubiquitin ligation. Thus, our findings support previous data that place the ubiquitin-proteasome system as a promising candidate for its involvement in the aetiology of ADHD., Over the course of this investigation, I.G. M. has been a recipient of a predoctoral fellowship from the Vall d’Hebron Research Institute (PRED-VHIR-2012), Barcelona, Spain, and currently she is a recipient of a contract from the 7th Framework Programme for Research, Technological Development and Demonstration, European Commission (AGGRESSOTYPE_FP7HEALTH2013/602805). C.S. M. is a recipient of a Sara Borrell contract from the Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spain (CD15/00199) and a mobility grant from the Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spain (MV16/00039). M.S. A. is a recipient of a contract from the Biomedical Research Networking Centre in Mental Health (CIBERSAM), Madrid, Spain. P.R. is a recipient of a predoctoral fellowship from the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Spain (2016FI_B 00899). M.P. is recipient of a predoctoral fellowship from the Vall d’Hebron Research Institute, Barcelona, Spain (PRED-VHIR-2013) and a research grant from the Deutscher Akademischer Austauschdienst (DAAD), Germany (Research Grants - Short-Term Grants, 2017). E.C. S. is a recipient of a predoctoral fellowship from the Collaborative Research Training Programme for Medical Doctors (PhD4MD), Centre for Genomic Regulation (CRG) and Vall d’Hebron Research Institute (VHIR), Barcelona, Spain (II14/00018). M.R. is a recipient of a Miguel de Servet contract from the Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad, Spain (CP09/00119 and CPII15/00023). This investigation was supported by Instituto de Salud Carlos III (PI12/01139, PI14/01700, PI15/01789, PI16/01505), and cofinanced by the European Regional Development Fund (ERDF), Agència de Gestió d’Ajuts Universitaris i de Recerca-AGAUR, Generalitat de Catalunya (2014SGR1357, 2014SGR0932), Ministerio de Economía, Industria y Competitividad, Spain (SAF2012-33484, SAF2015-68341-R), the European College of Neuropsychopharmacology (ECNP network: ‘ADHD across the lifespan’), Departament de Salut, Generalitat de Catalunya, Spain, and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. This project has also received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the grant agreements No 667302 and 643051.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

  • Postema, Merel C.
  • Vilarroya, Óscar
  • Francks, Clyde
Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

  • Pagerols Teixidó, Mireia
  • Richarte, Vanesa
  • Sánchez Mora, Cristina
  • Rovira, Paula
  • Soler Artigas, María
  • Garcia-Martínez, Iris
  • Calvo-Sánchez, Eva
  • Corrales, Montserrat
  • Santos da Silva, Bruna
  • Roth-Mota, Nina
  • Victor, Marcelo Moraes
  • Rohde, Luis Augusto
  • Grevet, Eugenio Horacio
  • Bau, Claiton Henrique Dotto
  • Cormand Rifà, Bru
  • Casas, Miquel
  • Ramos Quiroga, Josep Antoni
  • Ribasés Haro, Marta
Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD paediatric patients. Although no variant reached genome-wide significance, the set of genes containing single-nucleotide polymorphisms (SNPs) nominally associated with MPH response (P < 0.05) was significantly enriched for candidates previously studied in ADHD or treatment outcome. We prioritised the nominally significant SNPs by functional annotation and expression quantitative trait loci (eQTL) analysis in human brain, and we identified 33 SNPs tagging cis-eQTL in 32 different loci (referred to as eSNPs and eGenes, respectively). Pathway enrichment analyses revealed an over-representation of genes involved in nervous system development and function among the eGenes. Categories related to neurological diseases, psychological disorders and behaviour were also significantly enriched. We subsequently meta-analysed the association with clinical outcome for the 33 eSNPs across the discovery sample and an independent cohort of 189 ADHD adult patients (target sample) and we detected 15 suggestive signals. Following this comprehensive strategy, our results provide a better understanding of the molecular mechanisms implicated in MPH treatment effects and suggest promising candidates that may encourage future studies.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder

  • Pineda Cirera, Laura
  • Shivalikanjli, Anu
  • Cabana Domínguez, Judit
  • Demontis, Ditte
  • Rajagopal, Veera M.
  • Børglum, Anders D.
  • Faraone, Stephen V.
  • Cormand Rifà, Bru
  • Fernàndez Castillo, Noèlia
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder caused by an interplay of genetic and environmental factors. Epigenetics is crucial to lasting changes in gene expression in the brain. Recent studies suggest a role for DNA methylation in ADHD. We explored the contribution to ADHD of allele-specific methylation (ASM), an epigenetic mechanism that involves SNPs correlating with differential levels of DNA methylation at CpG sites. We selected 3896 tagSNPs reported to influence methylation in human brain regions and performed a case-control association study using the summary statistics from the largest GWAS meta-analysis of ADHD, comprising 20,183 cases and 35,191 controls. We observed that genetic risk variants for ADHD are enriched in ASM SNPs and identified associations with eight tagSNPs that were significant at a 5% false discovery rate (FDR). These SNPs correlated with methylation of CpG sites lying in the promoter regions of six genes. Since methylation may affect gene expression, we inspected these ASM SNPs together with 52 ASM SNPs in high LD with them for eQTLs in brain tissues and observed that the expression of three of those genes was affected by them. ADHD risk alleles correlated with increased expression (and decreased methylation) of ARTN and PIDD1 and with a decreased expression (and increased methylation) of C2orf82. Furthermore, these three genes were predicted to have altered expression in ADHD, and genetic variants in C2orf82 correlated with brain volumes. In summary, we followed a systematic approach to identify risk variants for ADHD that correlated with differential cis-methylation, identifying three novel genes contributing to the disorder.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller Cucala, Paula
  • Maceda Porto, Iago, 1986-
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand, Bru
  • Lao Grueso, Oscar, 1976-
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, the co-funding by the Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. O.L. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia) - GRC 2017 SGR 937, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302 and EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051. P.E.-C. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - FI_B1_00113. I.M. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - GRC 2014 SGR 615. A.D.B. and D.D. were supported by the Lundbeck Foundation (grant numbers R102-A9118 and R155-2014-1724). S.V.F. was supported by the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement - 602805, the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 667302 & 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. B.C. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - SAF2015-68341-R and RTI2018-100968-B-100, Generalitat de Catalunya | Agaur (Government of Catalonia) - GRC 2017 SGR 738, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302, EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051 and EC | EU Horizon 2020 Research and Innovation Proramme (Sustainable Food Security - Resilient and Resource - Efficient Value Chains) - 728018
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence

  • Fernàndez Castillo, Noèlia
  • Cabana Domínguez, Judit
  • Soriano i Fradera, Jordi
  • Sánchez Mora, Cristina
  • Roncero, Carlos
  • Grau-López, Lara
  • Ros Cucurull, Elena
  • Daigre, Constanza
  • Van Donkelaar, Marjolein M. J.
  • Franke, B.
  • Casas, Miquel
  • Ribasés Haro, Marta
  • Cormand Rifà, Bru
Cocaine reward and reinforcing effects are mediated mainly by dopaminergic neurotransmission. In this study, we aimed at evaluating gene expression changes induced by acute cocaine exposure on SH-SY5Y-differentiated cells, which have been widely used as a dopaminergic neuronal model. Expression changes and a concomitant increase in neuronal activity were observed after a 5 μM cocaine exposure, whereas no changes in gene expression or in neuronal activity took place at 1 μM cocaine. Changes in gene expression were identified in a total of 756 genes, mainly related to regulation of transcription and gene expression, cell cycle, adhesion and cell projection, as well as mitogen-activeated protein kinase (MAPK), CREB, neurotrophin and neuregulin signaling pathways. Some genes displaying altered expression were subsequently targeted with predicted functional single-nucleotide polymorphisms (SNPs) in a case-control association study in a sample of 806 cocaine-dependent patients and 817 controls. This study highlighted associations between cocaine dependence and five SNPs predicted to alter microRNA binding at the 3′-untranslated region of the NFAT5 gene. The association of SNP rs1437134 with cocaine dependence survived the Bonferroni correction for multiple testing. A functional effect was confirmed for this variant by a luciferase reporter assay, with lower expression observed for the rs1437134G allele, which was more pronounced in the presence of hsa-miR-509. However, brain volumes in regions of relevance to addiction, as assessed with magnetic resonance imaging, did not correlate with NFAT5 variation. These results suggest that the NFAT5 gene, which is upregulated a few hours after cocaine exposure, may be involved in the genetic predisposition to cocaine dependence.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

  • Rovira, Paula
  • Demontis, Ditte
  • Sánchez Mora, Cristina
  • Zayats, Tetyana
  • Klein, Marieke
  • Roth Mota, Nina
  • Weber, Heike
  • Garcia-Martínez, Iris
  • Pagerols Teixidó, Mireia
  • Vilar, Laura
  • Arribas, Lorena
  • Richarte, Vanesa
  • Corrales, Montserrat
  • Fadeuilhe, Christian
  • Bosch, Rosa
  • Español, Gemma
  • Grevet, Eugenio Horacio
  • Halmøy, Anne
  • Hutz, Mara
  • Knappskog, Per M.
  • Lundervold, Aastri J.
  • Rovaris, Diego Luiz
  • Santos da Silva, Bruna
  • Sprooten, Emma
  • ADHD Working Group of the Psychiatric Genomics Consortium
  • Arias Vasquez, Alejandro
  • Sonuga-Barke, Edmund
  • Asherson, Philip
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan K.
  • Cormand Rifà, Bru
  • Faraone, Stephen V.
  • Haavik, Jan
  • Johansson, Stefan E.
  • Kuntsi, Jonna
  • Larsson, Henrik
  • Lesch, Klaus-Peter
  • Reif, Andreas
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas, Jordi
  • Klein, Marieke
  • Zayats, Tetyana
  • Rivero, Olga
  • Ziegler, Georg C.
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy
  • Geissler, Julia
  • Weber, Heike
  • Reif, Andreas
  • Arias Vasquez, Alejandro
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan K.
  • Ramos Quiroga, Josep Antoni
  • Cormand Rifà, Bru
  • Ribasés Haro, Marta
  • Hveem, Kristian
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara
  • Lesch, Klaus-Peter
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (Ntotal = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Involvement of the 14-3-3 gene family in autism spectrum disorder and schizophrenia: Genetics, transcriptomics and functional analyses

  • Torrico Avilés, Bàrbara
  • Antón Galindo, Ester
  • Fernàndez Castillo, Noèlia
  • Rojo Francàs, Eva
  • Ghorbani, Sadaf
  • Pineda Cirera, Laura
  • Hervás, Amaia
  • Rueda, Isabel
  • Moreno Guillén, Estefanía
  • Fullerton, Janice M.
  • Casadó, Vicent
  • Buitelaar, Jan K.
  • Rommelse, Nanda
  • Franke, Barbara
  • Reif, Andreas
  • Chiocchetti, Andreas G.
  • Freitag, Christine
  • Kleppe, Rune
  • Haavik, Jan
  • Toma, Claudio
  • Cormand Rifà, Bru
The 14-3-3 protein family are molecular chaperones involved in several biological functions and neurological diseases. We previously pinpointed YWHAZ (encoding 14-3-3ζ) as a candidate gene for autism spectrum disorder (ASD) through a whole-exome sequencing study, which identified a frameshift variant within the gene (c.659-660insT, p.L220Ffs*18). Here, we explored the contribution of the seven human 14-3-3 family members in ASD and other psychiatric disorders by investigating the: (i) functional impact of the 14-3-3ζ mutation p.L220Ffs*18 by assessing solubility, target binding and dimerization; (ii) contribution of common risk variants in 14-3-3 genes to ASD and additional psychiatric disorders; (iii) burden of rare variants in ASD and schizophrenia; and iv) 14-3-3 gene expression using ASD and schizophrenia transcriptomic data. We found that the mutant 14-3-3ζ protein had decreased solubility and lost its ability to form heterodimers and bind to its target tyrosine hydroxylase. Gene-based analyses using publicly available datasets revealed that common variants in YWHAE contribute to schizophrenia (p = 6.6 × 10-7), whereas ultra-rare variants were found enriched in ASD across the 14-3-3 genes (p = 0.017) and in schizophrenia for YWHAZ (meta-p = 0.017). Furthermore, expression of 14-3-3 genes was altered in post-mortem brains of ASD and schizophrenia patients. Our study supports a role for the 14-3-3 family in ASD and schizophrenia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Characterisation of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Vicente García, Cristina
  • Mirra, Serena
  • Burguera Hernández, Demian
  • Fernàndez Castillo, Noèlia
  • Ferrán, José Luis
  • López Mayorga, Macarena
  • Alaiz Noya, Marta
  • Suárez Pereira, Irene
  • Antón Galindo, Ester
  • Ulloa Darquea, Fausto Alexander
  • Herrera Úbeda, Carlos
  • Cuscó, Pol
  • Falcón Moya, Rafael
  • Rodríguez Moreno, Antonio
  • D'Aniello, Salvatore
  • Cormand Rifà, Bru
  • Marfany i Nadal, Gemma
  • Soriano García, Eduardo
  • Carrión, Ángel M.
  • Carvajal, Jaime J.
  • Garcia Fernández, Jordi
Background One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/- mice

  • Cabana-Domínguez, Judit
  • Martín García, Elena, 1975-
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernández-Castillo, Noèlia
  • Comand, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction., This work was supported by the Spanish ‘Ministerio de Economía y Competitividad-MINECO’ (#SAF2017-84060-RAEI/FEDER-UE), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I068) to RM, ‘Fundació La Marató-TV3’ (#2016/20-30) and ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006) to EMG, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100), Spanish ‘Ministerio de Economía y Competitividad’ (#SAF2015-68341-R), ‘AGAURGeneralitat de Catalunya’ (#2017-SGR-738) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I050) to BC and (#PNSD-2020I042) to NFC. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE). JCD was supported by the H2020 CoCA and Eat2beNICE projects
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Characterization of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Cuscó Pons, Pol, 1987-
  • García Fernàndez, Jordi
Background: One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results: Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions: We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders., Major financial support for this research was received from Spanish “Ministerio de Ciencia, Innovación y Universidades.” Grants BFU2015-68655-P and BFU2017-861152-P to J.G.F., RTI2018-100968-B-I00, 2017-SGR-738, H2020/2014-2020 under grant agreements n°667302, n°643051, and n°728018 to B.C., PGC2018-098229-B-I00 to J.L.F., BES-2016-077374 to E.A.-G., CVI-7290 Junta de Andalucía to A.R.M., SAF2016-80937-R (Ministerio de Economía y Competitividad/FEDER) to G.M., Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and BFU2017-83150-P to J.J.C, BFU2017-89780-R and P12-CTS-2257 to A.M.C. and SAF2016-76340-R and María de Maeztu Excellence Unit, Institute of Neurosciences to E.S.. E.N.P. held an FPI pre-doctoral fellowship (Spanish “Ministerio de Ciencia, Innovación y Universidades”).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures

  • Roth Mota, Nina
  • Poelmans, Geert
  • Klein, Marieke
  • Torrico, Bàrbara
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
  • Reif, Andreas
  • Franke, Barbara
  • Arias Vasquez, Alejandro
Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N = 53,293, N = 681,275, and N = 98,697, respectively). We then conducted genome-wide ADHD-BMI and ADHD-obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD-BMI overlapping genes with brain volumes (primary GWAS data N = 10,720-10,928; replication data N = 9428). The dopaminergic gene set was associated with both ADHD (P = 5.81 × 10−3) and BMI (P = 1.63 × 10−5); the circadian rhythm was associated with BMI (P = 1.28 × 10−3). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD-BMI and ADHD-obesity results. The ADHD-BMI overlapping genes were associated with putamen volume (P = 7.7 × 10−3; replication data P = 3.9 × 10−2) a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD-obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  • Franke, Barbara
  • Michelini, Giorgia
  • Asherson, Philip
  • Banaschewski, Tobias
  • Bilbow, Andrea
  • Buitelaar, Jan K.
  • Cormand Rifà, Bru
  • Faraone, Stephen V.
  • Ginsberg, Yiva
  • Haavik, Jan
  • Kuntsi, Jonna
  • Larsson, Henrik
  • Lesch, Klaus-Peter
  • Ramos-Quiroga, Josep Antoni
  • Réthelyi, János M.
  • Ribasés Haro, Marta
  • Reif, Andreas
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian Disorders presenting with hyperactivity and/or inattention

  • Fernàndez Castillo, Noèlia
  • Cabana Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico Avilés, Bàrbara
  • Weber, Heike
  • Lesch, Klaus-Peter
  • Lao, Oscar
  • Reif, Andreas
  • Cormand Rifà, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD.We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder

  • García Martínez, Iris
  • Sánchez Mora, Cristina
  • Soler Artigas, María
  • Rovira, Paula
  • Pagerols Teixidó, Mireia
  • Corrales, Montserrat
  • Calvo Sánchez, Eva
  • Richarte, Vanesa
  • Bustamante Pineda, Mariona
  • Sunyer Deu, Jordi
  • Cormand Rifà, Bru
  • Casas, Miquel
  • Ramos Quiroga, Josep Antoni
  • Ribasés Haro, Marta
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood-onset neurodevelopmental condition characterized by pervasive impairment of attention, hyperactivity, and/or impulsivity that can persist into adulthood. The aetiology of ADHD is complex and multifactorial and, despite the wealth of evidence for its high heritability, genetic studies have provided modest evidence for the involvement of specific genes and have failed to identify consistent and replicable results. Due to the lack of robust findings, we performed gene-wide and pathway enrichment analyses using pre-existing GWAS data from 607 persistent ADHD subjects and 584 controls, produced by our group. Subsequently, expression profiles of genes surpassing a follow-up threshold of P-value < 1e-03 in the gene-wide analyses were tested in peripheral blood mononucleated cells (PBMCs) of 45 medication-naive adults with ADHD and 39 healthy unrelated controls. We found preliminary evidence for genetic association between RNF122 and ADHD and for its overexpression in adults with ADHD. RNF122 encodes for an E3 ubiquitin ligase involved in the proteasome-mediated processing, trafficking, and degradation of proteins that acts as an essential mediator of the substrate specificity of ubiquitin ligation. Thus, our findings support previous data that place the ubiquitin-proteasome system as a promising candidate for its involvement in the aetiology of ADHD.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian disorders presenting with hyperactivity and/or inattention

  • Fernàndez-Castillo, Noèlia
  • Cabana-Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico, Bàrbara
  • Weber, Keike
  • Lesch, Klaus-Peter
  • Lao Grueso, Oscar, 1976-
  • Reif, Andreas
  • Cormand, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD. We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders., This work was supported mainly by funding from the European Union H2020 Program [H2020/2014–2020, grant agreements n° 667302, 643051 and 728018, corresponding to projects CoCA, coca-project.eu/; Eat2BeNice: newbrainnutrition.com/ (accessed on 16 December 2021); and MiND; www.mind-project.eu (accessed on 16 December 2021), respectively], and from the ‘ECNP network on ADHD across the lifespan’. NC-F received funding from ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health‘ [PNSD-2020I042] and was supported by a contract of the ‘Centro de Investigación Biomédica en Red de Enfermedades Raras' (CIBERER). BC received funding from the Spanish ‘Ministerio de Economía y Competitividad’ [SAF2015-68341-R, RTI2018-100968-B-100 and PID2021-1277760B-I100], ‘Plan Nacional sobre Drogas of the Spanish Ministry of Health’ [PNSD-2017I050] and AGAUR, ‘Generalitat de Catalunya’ [2017-SGR-738]. JC-D and BT were supported by the H2020 CoCA (n° 667302) and Eat2beNICE (n° 728018) projects. DBK was supported by the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 643051 (MiND) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-148273/2016-5). OL acknowledges the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020, Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness)—RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00 and Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine seeking behavior in Plcb1+/- mice

  • Cabana Domínguez, Judit
  • Martín-García, Elena
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Diminished modulation of preparatory sensorimotor mu rhythm predicts attention-deficit/hyperactivity disorder severity

  • ter Huurne, N.
  • Lozano-Soldevilla, D.
  • Onnink, M.
  • Kan, C.
  • Buitelaar, J.
  • Jensen, O.
The authors gratefully acknowledge funding from The Netherlands Organization for Scientific Research (NWO): a VICI grant (453–09–002) to O.J., and from Karakter Child and Adolescent Psychiatry to N.t.H. The work of J.B. for the current paper is supported by the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 278948 (TACTICS) and from the European Community’s Horizon 2020 Programme (H2020/2014–2020) under grant agreements no. 643051 (MiND) and no. 642996 (BRAINVIEW)., Background: Attention-deficit/hyperactivity disorder (ADHD) is characterized by problems in regulating attention and in suppressing disruptive motor activity, i.e. hyperactivity and impulsivity. We recently found evidence that aberrant distribution of posterior α band oscillations (8–12 Hz) is associated with attentional problems in ADHD. The sensorimotor cortex also produces strong 8–12 Hz band oscillations, namely the μ rhythm, and is thought to have a similar inhibitory function. Here, we now investigate whether problems in distributing α band oscillations in ADHD generalize to the μ rhythm in the sensorimotor domain. Method: In a group of adult ADHD (n = 17) and healthy control subjects (n = 18; aged 21–40 years) oscillatory brain activity was recorded using magnetoencephalography during a visuo-spatial attention task. Subjects had to anticipate a target with unpredictable timing and respond by pressing a button. Results: Preparing a motor response, the ADHD group failed to increase hemispheric μ lateralization with relatively higher μ power in sensorimotor regions not engaged in the task, as the controls did (F1,33 = 8.70, p = 0.006). Moreover, the ADHD group pre-response μ lateralization not only correlated positively with accuracy (rs = 0.64, p = 0.0052) and negatively with intra-individual reaction time variability (rs = −0.52, p = 0.033), but it also correlated negatively with the score on an ADHD rating scale (rs = −0.53, p = 0.028). Conclusions: We suggest that ADHD is associated with an inability to sufficiently inhibit task-irrelevant sensorimotor areas by means of modulating μ oscillatory activity. This could explain disruptive motor activity in ADHD. These results provide further evidence that impaired modulation of α band oscillations is involved in the pathogenesis of ADHD., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis

  • Jakobi, Babette
  • Vlaming, Priscilla
  • Mulder, Danique
  • Richarte, Vanesa
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
ADHD; Gut-microbiota, TDAH; Microbiota intestinal, TDAH; Microbiota intestinal, Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that persists into adulthood in the majority of individuals. While the gut-microbiome seems to be relevant for ADHD, the few publications on gut-microbial alterations in ADHD are inconsistent, in the investigated phenotypes, sequencing method/region, preprocessing, statistical approaches, and findings. To identify gut-microbiome alterations in adult ADHD, robust across studies and statistical approaches, we harmonized bioinformatic pipelines and analyses of raw 16S rRNA sequencing data from four adult ADHD case-control studies (NADHD=312, NNoADHD=305). We investigated diversity and differential abundance of selected genera (logistic regression and ANOVA-like Differential Expression tool), corrected for age and sex, and meta-analyzed the study results. Converging results were investigated for association with hyperactive/impulsive and inattentive symptoms across all participants. Beta diversity was associated with ADHD diagnosis but showed significant heterogeneity between cohorts, despite harmonized analyses. Several genera were robustly associated with adult ADHD; e.g., Ruminococcus_torques_group (LogOdds=0.17, pfdr=4.42 × 10-2), which was more abundant in adults with ADHD, and Eubacterium_xylanophilum_group (LogOdds= -0.12, pfdr=6.9 × 10-3), which was less abundant in ADHD. Ruminococcus_torques_group was further associated with hyperactivity/impulsivity symptoms and Eisenbergiella with inattention and hyperactivity/impulsivity (pfdr<0.05). The literature points towards a role of these genera in inflammatory processes. Irreproducible results in the field of gut-microbiota research, due to between study heterogeneity and small sample sizes, stress the need for meta-analytic approaches and large sample sizes. While we robustly identified genera associated with adult ADHD, that might overall be considered beneficial or risk-conferring, functional studies are needed to shed light on these properties., This project was supported by grants from National Institutes of Health (grant R01MH62873 to SV Faraone) for initial sample recruitment, and from NWO Large Investment (grant 1750102007010 to JK Buitelaar), NWO Brain & Cognition (grant 433-09-242 to JK Buitelaar), and grants from Radboud University Medical Center, University Medical Center Groningen, Accare, and VU University Amsterdam for subsequent assessment waves. NeuroIMAGE also received funding from the European Community's Seventh Framework Programme (FP7/2007 – 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreements n° 643051 (MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). IMpACT: We acknowledge funding from the Netherlands Organization for Scientific Research (NWO), i.e. the Veni Innovation Program (grant 016-196-115 to MH) and the Vici Innovation Program (grant 016–130-669 to BF). The work was also supported by the European College of Neuropsychopharmacology (ECNP) Network “ADHD Across the Lifespan”. BJ and BF were also supported by funding from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreement n 847879 (PRIME).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder

  • Brevik, Erlend J.
  • van Donkelaar, Marjolein M. J.
  • Weber, Heike|||0000-0002-9421-1292
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Jacob, Christian P.
  • Rivero, Olga|||0000-0002-2664-4053
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Aebi, Marcel
  • van Hulzen, Kimm
  • Cormand, Bru|||0000-0001-5318-4382
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Reif, Andreas|||0000-0002-0992-634X
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Franke, Barbara|||0000-0003-4375-6572
  • Posserud, Maj-Britt
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Lundervold, Astri J.|||0000-0002-6819-6164
  • Haavik, Jan|||0000-0001-7865-2808
  • Zayats, Tetyana
Aggressiveness is a behavioral trait that has the potential to be harmful to individuals and society. With an estimated heritability of about 40%, genetics is important in its development. We performed an exploratory genome-wide association (GWA) analysis of childhood aggressiveness in attention deficit hyperactivity disorder (ADHD) to gain insight into the underlying biological processes associated with this trait. Our primary sample consisted of 1,060 adult ADHD patients (aADHD). To further explore the genetic architecture of childhood aggressiveness, we performed enrichment analyses of suggestive genome-wide associations observed in aADHD among GWA signals of dimensions of oppositionality (defiant/vindictive and irritable dimensions) in childhood ADHD (cADHD). No single polymorphism reached genome-wide significance (P < 5.00E-08). The strongest signal in aADHD was observed at rs10826548, within a long noncoding RNA gene (beta = -1.66, standard error (SE) = 0.34, P = 1.07E-06), closely followed by rs35974940 in the neurotrimin gene (beta = 3.23, SE = 0.67, P = 1.26E-06). The top GWA SNPs observed in aADHD showed significant enrichment of signals from both the defiant/vindictive dimension (Fisher's P -value = 2.28E-06) and the irritable dimension in cADHD (Fisher's P -value = 0.0061). In sum, our results identify a number of biologically interesting markers possibly underlying childhood aggressiveness and provide targets for further genetic exploration of aggressiveness across psychiatric disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder

  • Garcia Martínez, I.
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas, M.
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés, M..
Attention deficit and hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by impairment to sustain attention and inability to control impulses and activity level. The etiology of ADHD is complex, with an estimated heritability of 70-80%. Under the hypothesis that alterations in the processing or target binding of microRNAs (miRNAs) may result in functional alterations predisposing to ADHD, we explored whether common polymorphisms potentially affecting miRNA-mediated regulation are involved in this psychiatric disorder. We performed a comprehensive association study focused on 134 miRNAs in 754 ADHD subjects and 766 controls and found association between the miR-34b/c locus and ADHD. Subsequently, we provided preliminary evidence for overexpression of the miR-34c-3p mature form in peripheral blood mononuclear cells of ADHD subjects. Next, we tested the effect on gene expression of single-nucleotide polymorphisms within the ADHD-associated region and found that rs4938923 in the promoter of the pri-miR-34b/c tags cis expression quantitative trait loci for both miR-34b and miR-34c and has an impact on the expression levels of 681 transcripts in trans, including genes previously associated with ADHD. This gene set was enriched for miR-34b/c binding sites, functional categories related to the central nervous system, such as axon guidance or neuron differentiation, and serotonin biosynthesis and signaling canonical pathways. Our results provide preliminary evidence for the contribution to ADHD of a functional variant in the pri-miR-34b/c promoter, possibly through dysregulation of the expression of mature forms of miR-34b and miR-34c and some target genes. These data highlight the importance of abnormal miRNA function as a potential epigenetic mechanism contributing to ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exome chip analyses in adult attention deficit hyperactivity disorder

  • Zayats, Tetyana
  • Jacobsen, K. K.
  • Kleppe, R.
  • Jacob, Christian P.
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • Ribasés, M..
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Mota, N. R.
  • Grevet, Eugenio Horacio
  • Klein, M.
  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Bralten, Janita|||0000-0003-1440-8675
  • Galesloot, Tessel E.
  • Vasquez, A. A.
  • Herms, Stefan|||0000-0002-2786-8200
  • Forstner, A. J.
  • Larsson, Henrik
  • Breen, G.
  • Asherson, Philip|||0000-0003-2667-2254
  • Gross-Lesch, S.
  • Lesch, K. P.
  • Cichon, Sven|||0000-0002-9475-086X
  • Gabrielsen, M. B.
  • Holmen, O. L.
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Kiemeney, L.
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Cormand, Bru|||0000-0001-5318-4382
  • Franke, Barbara|||0000-0003-4375-6572
  • Reif, Andreas|||0000-0002-0992-634X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, S..
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable childhood-onset neuropsychiatric condition, often persisting into adulthood. The genetic architecture of ADHD, particularly in adults, is largely unknown. We performed an exome-wide scan of adult ADHD using the Illumina Human Exome Bead Chip, which interrogates over 250 000 common and rare variants. Participants were recruited by the International Multicenter persistent ADHD CollaboraTion (IMpACT). Statistical analyses were divided into 3 steps: (1) gene-level analysis of rare variants (minor allele frequency (MAF)<1%); (2) single marker association tests of common variants (MAF⩾1%), with replication of the top signals; and (3) pathway analyses. In total, 9365 individuals (1846 cases and 7519 controls) were examined. Replication of the most associated common variants was attempted in 9847 individuals (2077 cases and 7770 controls) using fixed-effects inverse variance meta-analysis. With a Bonferroni-corrected significance level of 1.82E-06, our analyses of rare coding variants revealed four study-wide significant loci: 6q22.1 locus (P =4.46E-08), where NT5DC1 and COL10A1 reside; the SEC23IP locus (P =6.47E-07); the PSD locus (P =7.58E-08) and ZCCHC4 locus (P =1.79E-06). No genome-wide significant association was observed among the common variants. The strongest signal was noted at rs9325032 in PPP2R2B (odds ratio=0.81, P =1.61E-05). Taken together, our data add to the growing evidence of general signal transduction molecules (NT5DC1, PSD, SEC23IP and ZCCHC4) having an important role in the etiology of ADHD. Although the biological implications of these findings need to be further explored, they highlight the possible role of cellular communication as a potential core component in the development of both adult and childhood forms of ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  • Franke, Barbara|||0000-0003-4375-6572
  • Michelini, Giorgia
  • Asherson, Philip|||0000-0003-2667-2254
  • Banaschewski, Tobias
  • Bilbow, Andrea
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Cormand, Bru|||0000-0001-5318-4382
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Ginsberg, Ylva
  • Haavik, Jan|||0000-0001-7865-2808
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Larsson, Henrik
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Réthelyi, János M.
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Reif, Andreas|||0000-0002-0992-634X
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

  • Rovira, Paula|||0000-0003-2177-8412
  • Demontis, Ditte|||0000-0001-9124-2766
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Zayats, Tetyana
  • Klein, Marieke|||0000-0001-8784-5679
  • Mota, Nina Roth
  • Weber, Heike|||0000-0002-9421-1292
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Arribas, Lorena|||0000-0002-9683-9999
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Bosch, Rosa|||0000-0002-7596-183X
  • Martin, Gemma Español
  • Almos, Peter
  • Doyle, Alysa E.
  • Grevet, Eugenio Horacio
  • Grimm, Oliver|||0000-0002-0767-0301
  • Halmøy, Anne
  • Hoogman, Martine|||0000-0002-1261-7628
  • Hutz, Mara
  • Jacob, Christian P.
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • Knappskog, Per M.
  • Lundervold, Astri J.|||0000-0002-6819-6164
  • Rivero, Olga|||0000-0002-2664-4053
  • Rovaris, Diego Luiz|||0000-0002-8910-4927
  • Salatino-Oliveira, Angelica
  • da Silva, Bruna Santos
  • Svirin, Evgeniy|||0000-0003-3501-574X
  • Sprooten, Emma
  • Strekalova, Tatyana
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Sonuga-Barke, Edmund J. S.
  • Asherson, Philip|||0000-0003-2667-2254
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Cormand, Bru|||0000-0001-5318-4382
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Larsson, Henrik
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Reif, Andreas|||0000-0002-0992-634X
  • Rohde, Luis Augusto
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Franke, Barbara|||0000-0003-4375-6572
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Klein, Marieke|||0000-0001-8784-5679
  • Zayats, Tetyana
  • Rivero, Olga|||0000-0002-2664-4053
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy|||0000-0003-3501-574X
  • Geissler, Julia
  • Weber, Heike|||0000-0002-9421-1292
  • Reif, Andreas|||0000-0002-0992-634X
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cormand, Bru|||0000-0001-5318-4382
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Hveem, Kristian|||0000-0001-8157-9744
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per|||0000-0002-6573-983X
  • Cichon, Sven|||0000-0002-9475-086X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara|||0000-0003-4375-6572
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (N = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder, lessons from CNTNAP2, ADGRL3, and PARK2

  • Dalla Vecchia, Elisa
  • Mortimer, Niall
  • Palladino, Viola S.
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Reif, Andreas|||0000-0002-0992-634X
  • Schenck, Annette
  • Norton, William H. J.
Animal and cellular models are essential tools for all areas of biological research including neuroscience. Model systems can also be used to investigate the pathophysiology of psychiatric disorders such as attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). In this review, we provide a summary of animal and cellular models for three genes linked to ADHD and ASD in human patients - CNTNAP2, ADGRL3, and PARK2. We also highlight the strengths and weaknesses of each model system. By bringing together behavioral and neurobiological data, we demonstrate how a cross-species approach can provide integrated insights into gene function and the pathogenesis of ADHD and ASD. The knowledge gained from transgenic models will be essential to discover and validate new treatment targets for these disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring the Contribution to ADHD of Genes Involved in Mendelian Disorders Presenting with Hyperactivity and/or Inattention

  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Kappel, Djenifer B.
  • Torrico, Bàrbara
  • Weber, Heike|||0000-0002-9421-1292
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Lao, Oscar
  • Reif, Andreas|||0000-0002-0992-634X
  • Cormand, Bru|||0000-0001-5318-4382
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD. We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cortical thickness across the lifespan, Data from 17,075 healthy individuals aged 3-90 years

  • Frangou, Sophia|||0000-0002-3210-6470
  • Modabbernia, Amirhossein
  • Williams, Steven C. R.
  • Papachristou, Efstathios
  • Doucet, Gaelle E.|||0000-0003-4120-0474
  • Agartz, Ingrid|||0000-0002-9839-5391
  • Aghajani, Moji|||0000-0003-2040-4881
  • Akudjedu, Theophilus|||0000-0003-2423-6897
  • Albajes-Eizagirre, Anton
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Andersson, Micael
  • Andreasen, Nancy C.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Asherson, Philip|||0000-0003-2667-2254
  • Banaschewski, Tobias
  • Bargalló, Núria|||0000-0001-6284-5402
  • Baumeister, Sarah
  • Baur-Streubel, Ramona
  • Bertolino, Alessandro
  • Bonvino, Aurora
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Borgwardt, Stefan
  • Bourque, Josiane
  • Brandeis, Daniel
  • Breier, Alan
  • Brodaty, Henry|||0000-0001-9487-6617
  • Brouwer, Rachel M.|||0000-0002-7466-1544
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Busatto, Geraldo F.
  • Buckner, Randy|||0000-0001-6422-8037
  • Calhoun, Vince
  • Canales-Rodriguez, Erick Jorge|||0000-0001-6421-2633
  • Cannon, Dara M.
  • Caseras, Xavier|||0000-0002-8490-6891
  • Castellanos, Francisco X.|||0000-0001-9192-9437
  • Cervenka, Simon
  • Chaim-Avancini, Tiffany M.
  • Ching, Christopher R. K.|||0000-0003-2921-3408
  • Chubar, Victoria
  • Clark, Vincent P.|||0000-0002-9151-2102
  • Conrod, Patricia
  • Conzelmann, Annette
  • Crespo-Facorro, Benedicto|||0000-0003-0033-7132
  • Crivello, Fabrice|||0000-0001-6950-984X
  • Crone, Eveline A.
  • Dale, Anders M.
  • Dannlowski, Udo|||0000-0002-0623-3759
  • Davey, Christopher|||0000-0003-1431-3852
  • de Geus, Eco J. C.|||0000-0001-6022-2666
  • Haan, Lieuwe de, 1960-|||0000-0002-3820-7926
  • de Zubicaray, Greig|||0000-0003-4506-0579
  • den Braber, A.
  • Dickie, Erin W.
  • Di Giorgio, Annabella
  • Doan, Nhat Trung
  • Dørum, Erlend S.
  • Ehrlich, Stefan|||0000-0003-2132-4445
  • Erk, Susanne
  • Espeseth, Thomas
  • Fatouros-Bergman, Helena|||0000-0003-4565-5839
  • Fisher, Simon E.|||0000-0002-3132-1996
  • Fouche, Jean-Paul|||0000-0002-0830-2324
  • Franke, Barbara|||0000-0003-4375-6572
  • Frodl, Thomas|||0000-0002-8113-6959
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Glahn, David C.|||0000-0002-4749-6977
  • Gotlib, Ian H.|||0000-0002-3622-3199
  • Grabe, Hans-Jörgen
  • Grimm, Oliver|||0000-0002-0767-0301
  • Groenewold, Nynke A.|||0000-0002-0865-8427
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Gruner, Patricia
  • Gur, Raquel E.
  • Gur, Ruben C.
  • Hahn, Tim|||0000-0002-8929-4134
  • Harrison, Ben J.
  • Hartman, Catharina A.
  • Hatton, Sean N.|||0000-0002-9149-8726
  • Heinz, Andreas
  • Heslenfeld, Dirk J.
  • Hibar, Derrek P.
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Ho, Beng-Choon|||0000-0003-3976-1555
  • Hoekstra, Pieter J.
  • Hohmann, Sarah
  • Holmes, Avram J.
  • Hoogman, Martine|||0000-0002-1261-7628
  • Hosten, Norbert
  • Howells, Fleur M.|||0000-0001-9759-2556
  • Hulshoff Pol, Hilleke E.|||0000-0002-2038-5281
  • Huyser, Chaim|||0000-0001-8757-3124
  • Jahanshad, Neda|||0000-0003-4401-8950
  • James, Anthony|||0000-0002-2742-8328
  • Jernigan, Terry L.
  • Jiang, Jiyang|||0000-0002-2147-6302
  • Jönsson, Erik G.|||0000-0001-8368-6332
  • Joska, John A.
  • Kahn, Rene
  • Kalnin, Andrew
  • Kanai, Ryota
  • Klein, Marieke|||0000-0001-8784-5679
  • Klyushnik, Tatyana P.
  • Koenders, Laura
  • Koops, Sanne
  • Krämer, Bernd|||0000-0002-1145-9103
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Lagopoulos, Jim
  • Lázaro, Luisa|||0000-0002-8425-5750
  • Lebedeva, Irina
  • Lee, Won Hee
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Lochner, Christine|||0000-0002-4766-3704
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Mazoyer, Bernard|||0000-0003-0970-2837
  • McDonald, Colm|||0000-0003-1661-5192
  • McDonald, Brenna C.
  • McIntosh, Andrew M.|||0000-0002-0198-4588
  • McMahon, Katie L.
  • McPhilemy, Genevieve
  • Meinert, Susanne|||0000-0003-2177-7161
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Meyer-Lindenberg, Andreas|||0000-0001-5619-1123
  • Naaijen, Jilly
  • Najt, Pablo
  • Nakao, Tomohiro
  • Nordvik, Jan E.
  • Nyberg, Lars
  • Oosterlaan, Jaap
  • de la Foz, Víctor Ortiz-García
  • Paloyelis, Yannis
  • Pauli, Paul
  • Pergola, Giulio
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Potkin, Steven G.
  • Radua, Joaquim|||0000-0003-1240-5438
  • Reif, Andreas|||0000-0002-0992-634X
  • Rinker, Daniel A.
  • Roffman, Joshua L.
  • Rosa, Pedro G. P.
  • Sacchet, Matthew D.
  • Sachdev, Perminder S.|||0000-0002-9595-3220
  • Salvador, Raymond|||0000-0001-5557-1562
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Sarró, Salvador|||0000-0003-1835-2189
  • Satterthwaite, Theodore D.|||0000-0001-7072-9399
  • Saykin, Andrew J.
  • Serpa, Mauricio H.
  • Schmaal, Lianne|||0000-0001-9822-048X
  • Schnell, Knut
  • Schumann, Gunter
  • Sim, Kang|||0000-0003-3209-9626
  • Smoller, Jordan W.|||0000-0002-0381-6334
  • Sommer, Iris
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Stein, Dan J.|||0000-0001-7218-7810
  • Strike, Lachlan|||0000-0003-2885-5898
  • Swagerman, Suzanne C.
  • Tamnes, Christian K.
  • Temmingh, Henk S.
  • Thomopoulos, Sophia I.|||0000-0002-0046-4070
  • Tomyshev, Alexander S.
  • Tordesillas-Gutiérrez, Diana
  • Trollor, Julian|||0000-0002-7685-2977
  • Turner, Jessica A.
  • Uhlmann, Anne|||0000-0002-1753-7811
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • van den Meer, Dennis
  • Van der Wee, Nic J. A.
  • van Haren, Neeltje E. M.
  • van 't Ent, Dennis
  • van Erp, Theo G. M.|||0000-0002-2465-2797
  • Veer, Ilya M.
  • Veltman, Dick J.
  • Voineskos, Aristotle|||0000-0003-0156-0395
  • Völzke, Henry|||0000-0001-7003-399X
  • Walter, Henrik|||0000-0002-9403-6121
  • Walton, Esther|||0000-0002-0935-2200
  • Wang, Lei
  • Wang, Yang
  • Wassink, Thomas H.
  • Weber, Bernd
  • Wen, Wei|||0000-0003-2753-3870
  • West, John D.
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Whalley, Heather|||0000-0002-4505-8869
  • Wierenga, Lara M.|||0000-0001-9362-563X
  • Wittfeld, Katharina|||0000-0003-4383-5043
  • Wolf, Daniel H.
  • Worker, Amanda
  • Wright, Margaret J.|||0000-0001-7133-4970
  • Yang, Kun
  • Yoncheva, Yuliya N.|||0000-0001-6495-7504
  • Zanetti, Marcus Vinicius|||0000-0001-7132-8933
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Dima, Danai|||0000-0002-2598-0952
Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes. We used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Greater male than female variability in regional brain structure across the lifespan

  • Wierenga, Lara M.|||0000-0001-9362-563X
  • Doucet, Gaelle E.|||0000-0003-4120-0474
  • Dima, Danai|||0000-0002-2598-0952
  • Agartz, Ingrid|||0000-0002-9839-5391
  • Aghajani, Moji|||0000-0003-2040-4881
  • Akudjedu, Theophilus|||0000-0003-2423-6897
  • Albajes-Eizagirre, Anton
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Anticevic, Alan
  • Asherson, Philip|||0000-0003-2667-2254
  • Banaschewski, Tobias
  • Bargalló, Núria|||0000-0001-6284-5402
  • Baumeister, Sarah
  • Baur-Streubel, Ramona
  • Bertolino, Alessandro
  • Bonvino, Aurora
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Borgwardt, Stefan
  • Bourque, Josiane
  • den Braber, A.
  • Brandeis, Daniel
  • Breier, Alan
  • Brodaty, Henry|||0000-0001-9487-6617
  • Brouwer, Rachel M.|||0000-0002-7466-1544
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Busatto, Geraldo F.
  • Calhoun, Vince
  • Canales-Rodriguez, Erick Jorge|||0000-0001-6421-2633
  • Cannon, Dara M.
  • Caseras, Xavier|||0000-0002-8490-6891
  • Castellanos, Francisco X.|||0000-0001-9192-9437
  • Chaim-Avancini, Tiffany M.
  • Ching, Christopher R. K.|||0000-0003-2921-3408
  • Clark, Vincent P.|||0000-0002-9151-2102
  • Conrod, Patricia
  • Conzelmann, Annette
  • Crivello, Fabrice|||0000-0001-6950-984X
  • Davey, Christopher|||0000-0003-1431-3852
  • Dickie, Erin W.
  • Ehrlich, Stefan|||0000-0003-2132-4445
  • van't Ent, Dennis
  • Fisher, Simon E.|||0000-0002-3132-1996
  • Fouche, Jean-Paul|||0000-0002-0830-2324
  • Franke, Barbara|||0000-0003-4375-6572
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • de Geus, Eco J. C.|||0000-0001-6022-2666
  • Di Giorgio, Annabella
  • Glahn, David C.|||0000-0002-4749-6977
  • Gotlib, Ian H.|||0000-0002-3622-3199
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Gruber, Oliver
  • Gruner, Patricia
  • Gur, Raquel E.
  • Gur, Ruben C.
  • Gurholt, Tiril Pedersen|||0000-0002-1272-7616
  • Haan, Lieuwe de, 1960-|||0000-0002-3820-7926
  • Haatveit, Beathe
  • Harrison, Ben J.
  • Hartman, Catharina A.
  • Hatton, Sean N.|||0000-0002-9149-8726
  • Heslenfeld, Dirk J.
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Hoekstra, Pieter J.
  • Hohmann, Sarah
  • Holmes, Avram J.
  • Hoogman, Martine|||0000-0002-1261-7628
  • Hosten, Norbert
  • Howells, Fleur M.|||0000-0001-9759-2556
  • Hulshoff Pol, Hilleke E.|||0000-0002-2038-5281
  • Huyser, Chaim|||0000-0001-8757-3124
  • Jahanshad, Neda|||0000-0003-4401-8950
  • James, Anthony|||0000-0002-2742-8328
  • Jiang, Jiyang|||0000-0002-2147-6302
  • Jönsson, Erik G.|||0000-0001-8368-6332
  • Joska, John A.
  • Kalnin, Andrew J.
  • Klein, Marieke|||0000-0001-8784-5679
  • Koenders, Laura
  • Kolskår, Knut K.|||0000-0003-3878-814X
  • Krämer, Bernd|||0000-0002-1145-9103
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Lagopoulos, Jim
  • Lázaro, Luisa|||0000-0002-8425-5750
  • Lebedeva, Irina
  • Lee, Phil H.
  • Lochner, Christine|||0000-0002-4766-3704
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Mazoyer, Bernard|||0000-0003-0970-2837
  • McDonald, Brenna C.
  • McDonald, Colm|||0000-0003-1661-5192
  • McIntosh, Andrew M.|||0000-0002-0198-4588
  • McMahon, Katie L.
  • McPhilemy, Genevieve
  • van der Meer, Dennis|||0000-0002-0466-386X
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Naaijen, Jilly
  • Nyberg, Lars
  • Oosterlaan, Jaap
  • Paloyelis, Yannis
  • Pauli, Paul
  • Pergola, Giulio
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Radua, Joaquim|||0000-0003-1240-5438
  • Reif, Andreas|||0000-0002-0992-634X
  • Richard, Geneviève
  • Roffman, Joshua L.
  • Rosa, Pedro G. P.
  • Sacchet, Matthew D.
  • Sachdev, Perminder S.|||0000-0002-9595-3220
  • Salvador, Raymond|||0000-0001-5557-1562
  • Sarró, Salvador|||0000-0003-1835-2189
  • Satterthwaite, Theodore D.|||0000-0001-7072-9399
  • Saykin, Andrew J.
  • Serpa, Mauricio H.
  • Sim, Kang|||0000-0003-3209-9626
  • Simmons, Andrew
  • Smoller, Jordan W.|||0000-0002-0381-6334
  • Sommer, Iris E.
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Stein, Dan J.|||0000-0001-7218-7810
  • Strike, Lachlan|||0000-0003-2885-5898
  • Szeszko, Philip R.
  • Temmingh, Henk S.
  • Thomopoulos, Sophia I.|||0000-0002-0046-4070
  • Tomyshev, Alexander S.
  • Trollor, Julian|||0000-0002-7685-2977
  • Uhlmann, Anne|||0000-0002-1753-7811
  • Veer, Ilya M.
  • Veltman, Dick J.
  • Voineskos, Aristotle|||0000-0003-0156-0395
  • Völzke, Henry|||0000-0001-7003-399X
  • Walter, Henrik|||0000-0002-9403-6121
  • Wang, Lei
  • Wang, Yang
  • Weber, Bernd
  • Wen, Wei|||0000-0003-2753-3870
  • West, John D.
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Whalley, Heather|||0000-0002-4505-8869
  • Williams, Steven C. R.
  • Wittfeld, Katharina|||0000-0003-4383-5043
  • Wolf, Daniel H.
  • Wright, Margaret J.|||0000-0001-7133-4970
  • Yoncheva, Yuliya N.|||0000-0001-6495-7504
  • Zanetti, Marcus Vinicius|||0000-0001-7132-8933
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • de Zubicaray, Greig|||0000-0003-4506-0579
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Crone, Eveline A.
  • Frangou, Sophia|||0000-0002-3210-6470
  • Tamnes, Christian K.
For many traits, males show greater variability than females, with possible implications for understanding sex differences in health and disease. Here, the ENIGMA (Enhancing Neuro Imaging Genetics through Meta-Analysis) Consortium presents the largest-ever mega-analysis of sex differences in variability of brain structure, based on international data spanning nine decades of life. Subcortical volumes, cortical surface area and cortical thickness were assessed in MRI data of 16,683 healthy individuals 1-90 years old (47% females). We observed significant patterns of greater male than female between-subject variance for all subcortical volumetric measures, all cortical surface area measures, and 60% of cortical thickness measures. This pattern was stable across the lifespan for 50% of the subcortical structures, 70% of the regional area measures, and nearly all regions for thickness. Our findings that these sex differences are present in childhood implicate early life genetic or gene-environment interaction mechanisms. The findings highlight the importance of individual differences within the sexes, that may underpin sex-specific vulnerability to disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Rovira, Paula|||0000-0003-2177-8412
  • Soler Artigas, María|||0000-0002-3213-1107
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Calvo-Sánchez, Eva|||0000-0001-8211-6047
  • Corrales, Montserrat|||0000-0002-7428-1402
  • da Silva, Bruna Santos
  • Mota, Nina Roth
  • Moraes Victor, Marcelo
  • Rohde, Luis Augusto
  • Grevet, Eugenio Horacio
  • Bau, Claiton Henrique Dotto
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD paediatric patients. Although no variant reached genome-wide significance, the set of genes containing single-nucleotide polymorphisms (SNPs) nominally associated with MPH response (P < 0.05) was significantly enriched for candidates previously studied in ADHD or treatment outcome. We prioritised the nominally significant SNPs by functional annotation and expression quantitative trait loci (eQTL) analysis in human brain, and we identified 33 SNPs tagging cis -eQTL in 32 different loci (referred to as eSNPs and eGenes, respectively). Pathway enrichment analyses revealed an over-representation of genes involved in nervous system development and function among the eGenes. Categories related to neurological diseases, psychological disorders and behaviour were also significantly enriched. We subsequently meta-analysed the association with clinical outcome for the 33 eSNPs across the discovery sample and an independent cohort of 189 ADHD adult patients (target sample) and we detected 15 suggestive signals. Following this comprehensive strategy, our results provide a better understanding of the molecular mechanisms implicated in MPH treatment effects and suggest promising candidates that may encourage future studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain, Algorithm Benchmarking and Model Optimization

  • Ge, Ruiyang
  • Yu, Yuetong
  • Qi, Yi Xuan
  • Fan, Yunan Vera
  • Chen, Shiyu
  • Gao, Chuntong
  • Haas, Shalaila S.
  • Modabbernia, Amirhossein
  • New, Faye
  • Agartz, Ingrid|||0000-0002-9839-5391
  • Asherson, Philip|||0000-0003-2667-2254
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Banaschewski, Tobias
  • Baumeister, Sarah
  • Bertolino, Alessandro
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Borgwardt, Stefan
  • Bourque, Josiane
  • Brandeis, Daniel
  • Breier, Alan
  • Brodaty, Henry|||0000-0001-9487-6617
  • Brouwer, Rachel M.|||0000-0002-7466-1544
  • Buckner, Randy|||0000-0001-6422-8037
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Cannon, Dara M.
  • Caseras, Xavier|||0000-0002-8490-6891
  • Cervenka, Simon
  • Conrod, Patricia
  • Crespo-Facorro, Benedicto|||0000-0003-0033-7132
  • Crivello, Fabrice|||0000-0001-6950-984X
  • Crone, Eveline A.
  • Haan, Lieuwe de, 1960-|||0000-0002-3820-7926
  • de Zubicaray, Greig|||0000-0003-4506-0579
  • Di Giorgio, Annabella
  • Erk, Susanne
  • Fisher, Simon E.|||0000-0002-3132-1996
  • Franke, Barbara|||0000-0003-4375-6572
  • Frodl, Thomas|||0000-0002-8113-6959
  • Glahn, David C.|||0000-0002-4749-6977
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Gruner, Patricia
  • Gur, Raquel E.
  • Gur, Ruben C.
  • Harrison, Ben J.
  • Hatton, Sean N.|||0000-0002-9149-8726
  • Hickie, Ian
  • Howells, Fleur M.|||0000-0001-9759-2556
  • Pol, Hilleke E Hulshoff
  • Huyser, Chaim|||0000-0001-8757-3124
  • Jernigan, Terry L.
  • Jiang, Jiyang|||0000-0002-2147-6302
  • Joska, John A.
  • Kahn, René S.
  • Kalnin, Andrew J.
  • Kochan, Nicole A.
  • Koops, Sanne
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Lagopoulos, Jim
  • Lázaro, Luisa|||0000-0002-8425-5750
  • Lebedeva, Irina
  • Lochner, Christine|||0000-0002-4766-3704
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Mazoyer, Bernard|||0000-0003-0970-2837
  • McDonald, Brenna C.
  • McDonald, Colm|||0000-0003-1661-5192
  • McMahon, Katie L.
  • Nakao, Tomohiro
  • Nyberg, Lars
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Qiu, Jiang
  • Roffman, Joshua L.
  • Sachdev, Perminder S.|||0000-0002-9595-3220
  • Sanford, Nicole
  • Satterthwaite, Theodore D.|||0000-0001-7072-9399
  • Saykin, Andrew J.
  • Schumann, Gunter
  • Sellgren, Carl M.
  • Sim, Kang|||0000-0003-3209-9626
  • Smoller, Jordan W.|||0000-0002-0381-6334
  • Soares, Jair
  • Sommer, Iris E.
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stein, Dan J.|||0000-0001-7218-7810
  • Tamnes, Christian K.
  • Thomopolous, Sophia I.
  • Tomyshev, Alexander S.
  • Tordesillas-Gutiérrez, Diana
  • Trollor, Julian|||0000-0002-7685-2977
  • van 't Ent, Dennis
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • van Erp, Theo GM.
  • van Haren, Neeltje EM.
  • Vecchio, Daniela
  • Veltman, Dick J.
  • Walter, Henrik|||0000-0002-9403-6121
  • Wang, Yang
  • Weber, Bernd
  • Wei, Dongtao
  • Wen, Wei|||0000-0003-2753-3870
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Wierenga, Lara M.|||0000-0001-9362-563X
  • Williams, Steven CR.
  • Wright, Margaret J.|||0000-0001-7133-4970
  • Medland, Sarah
  • Wu, Mon-Ju|||0000-0002-0540-8027
  • Yu, Kevin
  • Jahanshad, Neda|||0000-0003-4401-8950
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Frangou, Sophia|||0000-0002-3210-6470
We present an empirically benchmarked framework for sex-specific normative modeling of brain morphometry that can inform about the biological and behavioral significance of deviations from typical age-related neuroanatomical changes and support future study designs. This framework was developed using regional morphometric data from 37,407 healthy individuals (53% female; aged 3-90 years) following a comparative evaluation of eight algorithms and multiple covariate combinations pertaining to image acquisition and quality, parcellation software versions, global neuroimaging measures, and longitudinal stability. The Multivariate Factorial Polynomial Regression (MFPR) emerged as the preferred algorithm optimized using nonlinear polynomials for age and linear effects of global measures as covariates. The MFPR models showed excellent accuracy across the lifespan and within distinct age-bins, and longitudinal stability over a 2-year period. The performance of all MFPR models plateaued at sample sizes exceeding 3,000 study participants. The model and scripts described here are freely available through CentileBrain ().
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis

  • Jakobi, Babette
  • Vlaming, Priscilla
  • Mulder, Danique
  • Richarte, Vanesa
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
ADHD; Gut-microbiota, TDAH; Microbiota intestinal, TDAH; Microbiota intestinal, Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that persists into adulthood in the majority of individuals. While the gut-microbiome seems to be relevant for ADHD, the few publications on gut-microbial alterations in ADHD are inconsistent, in the investigated phenotypes, sequencing method/region, preprocessing, statistical approaches, and findings. To identify gut-microbiome alterations in adult ADHD, robust across studies and statistical approaches, we harmonized bioinformatic pipelines and analyses of raw 16S rRNA sequencing data from four adult ADHD case-control studies (NADHD=312, NNoADHD=305). We investigated diversity and differential abundance of selected genera (logistic regression and ANOVA-like Differential Expression tool), corrected for age and sex, and meta-analyzed the study results. Converging results were investigated for association with hyperactive/impulsive and inattentive symptoms across all participants. Beta diversity was associated with ADHD diagnosis but showed significant heterogeneity between cohorts, despite harmonized analyses. Several genera were robustly associated with adult ADHD; e.g., Ruminococcus_torques_group (LogOdds=0.17, pfdr=4.42 × 10-2), which was more abundant in adults with ADHD, and Eubacterium_xylanophilum_group (LogOdds= -0.12, pfdr=6.9 × 10-3), which was less abundant in ADHD. Ruminococcus_torques_group was further associated with hyperactivity/impulsivity symptoms and Eisenbergiella with inattention and hyperactivity/impulsivity (pfdr<0.05). The literature points towards a role of these genera in inflammatory processes. Irreproducible results in the field of gut-microbiota research, due to between study heterogeneity and small sample sizes, stress the need for meta-analytic approaches and large sample sizes. While we robustly identified genera associated with adult ADHD, that might overall be considered beneficial or risk-conferring, functional studies are needed to shed light on these properties., This project was supported by grants from National Institutes of Health (grant R01MH62873 to SV Faraone) for initial sample recruitment, and from NWO Large Investment (grant 1750102007010 to JK Buitelaar), NWO Brain & Cognition (grant 433-09-242 to JK Buitelaar), and grants from Radboud University Medical Center, University Medical Center Groningen, Accare, and VU University Amsterdam for subsequent assessment waves. NeuroIMAGE also received funding from the European Community's Seventh Framework Programme (FP7/2007 – 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreements n° 643051 (MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). IMpACT: We acknowledge funding from the Netherlands Organization for Scientific Research (NWO), i.e. the Veni Innovation Program (grant 016-196-115 to MH) and the Vici Innovation Program (grant 016–130-669 to BF). The work was also supported by the European College of Neuropsychopharmacology (ECNP) Network “ADHD Across the Lifespan”. BJ and BF were also supported by funding from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreement n 847879 (PRIME).